Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
__________________________________________________________ 
Form 10-Q
__________________________________________________________ 
ý
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2017
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from                  to                 
Commission File Number 001-37443
__________________________________________________________ 
Univar Inc.
(Exact name of registrant as specified in its charter)
__________________________________________________________ 
Delaware
 
26-1251958
(State or other jurisdiction of incorporation or organization)
 
(I.R.S. Employer Identification No.)
3075 Highland Parkway, Suite 200 Downers Grove, Illinois
 
60515
(Address of principal executive offices)
 
(Zip Code)
Registrant’s telephone number, including area code: (331) 777-6000
__________________________________________________________ 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes   ý      No   ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).     ý   Yes     ¨   No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one): 
Large accelerated filer
ý
Accelerated filer
¨
Non-accelerated filer
¨
Smaller reporting company
¨
Emerging growth company
¨
 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes   ¨     No   ý
At July 25, 2017 , 140,617,059 shares of the registrant’s common stock, $0.01 par value, were outstanding.


Table of Contents

Univar Inc.
Form 10-Q
For the quarterly period ended June 30, 2017
TABLE OF CONTENTS
 
Part I. FINANCIAL INFORMATION
Page
Item 1. Financial Statements (unaudited)
 
Condensed Consolidated Statements of Operations
Condensed Consolidated Statements of Comprehensive Income
Condensed Consolidated Balance Sheets
Condensed Consolidated Statements of Cash Flows
Condensed Consolidated Statements of Changes in Stockholders' Equity
Notes to Condensed Consolidated Statements
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosures About Market Risk
Item 4. Controls and Procedures
Part II. OTHER INFORMATION
 
Item 1. Legal Proceedings
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
Signatures

 


Table of Contents

PART I.
FINANCIAL INFORMATION

Item 1.
Financial Statements

Univar Inc.
Condensed Consolidated Statements of Operations
(Unaudited)
 
 
 
 
 
Three months ended June 30,
 
Six months ended June 30,
(in millions, except per share data)
 
Note  
 
2017

2016
 
2017
 
2016
Net sales
 
 
 
$
2,247.0


$
2,262.5

 
$
4,245.8

 
$
4,261.5

Cost of goods sold
 
 
 
1,780.6


1,817.1

 
3,340.0

 
3,385.8

Gross profit
 
 
 
$
466.4

 
$
445.4

 
$
905.8

 
$
875.7

Operating expenses:
 
 
 
 
 
 
 
 
 
 
Outbound freight and handling
 
 
 
71.9


73.3

 
142.9

 
144.6

Warehousing, selling and administrative
 
 
 
233.6


223.9

 
459.7

 
448.8

Other operating expenses, net
 
4
 
24.2


11.5

 
44.0

 
17.0

Depreciation
 
 
 
34.1


38.0

 
70.0

 
71.5

Amortization
 
 
 
16.5


23.3

 
33.2

 
45.3

Total operating expenses
 
 
 
$
380.3

 
$
370.0

 
$
749.8

 
$
727.2

Operating income
 
 
 
$
86.1

 
$
75.4

 
$
156.0

 
$
148.5

Other (expense) income:
 
 
 
 
 
 
 
 
 
 
Interest income
 
 
 
0.8


1.0

 
1.7

 
1.9

Interest expense
 
 
 
(36.6
)

(41.4
)
 
(73.3
)
 
(82.9
)
Loss on extinguishment of debt
 
 
 



 
(0.8
)
 

Other (expense) income, net
 
6
 
(11.7
)

5.7

 
(20.8
)
 
(7.7
)
Total other expense
 
 
 
$
(47.5
)
 
$
(34.7
)
 
$
(93.2
)
 
$
(88.7
)
Income before income taxes
 
 
 
38.6

 
40.7

 
62.8

 
59.8

Income tax expense
 
7
 
7.3


0.9

 
8.9

 
6.0

Net income
 
 
 
$
31.3


$
39.8

 
$
53.9

 
$
53.8

Income per common share:
 
 
 
 
 
 
 
 
 
 
Basic
 
8
 
$
0.22


$
0.29

 
$
0.38

 
$
0.39

Diluted
 
8
 
0.22


0.29

 
0.38

 
0.39

Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
 
 
Basic
 
8
 
140.1


137.6

 
139.8

 
137.6

Diluted
 
8
 
141.3


138.1

 
141.2

 
138.0

 










The accompanying notes are an integral part of these condensed consolidated financial statements.

1

Table of Contents

Univar Inc.
Condensed Consolidated Statements of Comprehensive Income
(Unaudited)
 
 
 
 
 
Three months ended
June 30,
 
Six months ended
June 30,
(in millions)
 
Note  
 
2017

2016
 
2017
 
2016
Net income
 
 
 
$
31.3


$
39.8

 
$
53.9

 
$
53.8

Foreign currency translation
 
9
 
45.0


(2.4
)
 
63.2

 
66.7

Pension and other postretirement benefit adjustment
 
9
 
(0.1
)

(1.2
)
 
(0.1
)
 
(3.0
)
Total other comprehensive income (loss), net of tax
 
 
 
$
44.9

 
$
(3.6
)
 
$
63.1

 
$
63.7

Comprehensive income
 
 
 
$
76.2

 
$
36.2

 
$
117.0

 
$
117.5












































The accompanying notes are an integral part of these condensed consolidated financial statements.

2

Table of Contents

Univar Inc.
Condensed Consolidated Balance Sheets
(Unaudited)
 
(in millions, except per share data)
 
Note  
 
June 30,
2017
 
December 31,
2016
Assets
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 
 
 
$
321.8

 
$
336.4

Trade accounts receivable, net
 
 
 
1,313.5

 
950.3

Inventories
 
 
 
817.3

 
756.6

Prepaid expenses and other current assets
 
 
 
151.6

 
134.8

Total current assets
 
 
 
$
2,604.2

 
$
2,178.1

Property, plant and equipment, net
 
11
 
1,008.8

 
1,019.5

Goodwill
 
 
 
1,800.5

 
1,784.4

Intangible assets, net
 
11
 
312.7

 
339.2

Deferred tax assets
 
 
 
24.0

 
18.2

Other assets
 
 
 
56.7

 
50.5

Total assets
 
 
 
$
5,806.9

 
$
5,389.9

Liabilities and stockholders’ equity
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
Short-term financing
 
10
 
$
19.4

 
$
25.3

Trade accounts payable
 
 
 
1,130.0

 
852.3

Current portion of long-term debt
 
10
 
99.3

 
109.0

Accrued compensation
 
 
 
72.6

 
65.6

Other accrued expenses
 
 
 
239.7

 
287.3

Total current liabilities
 
 
 
$
1,561.0

 
$
1,339.5

Long-term debt
 
10
 
2,895.5

 
2,845.0

Pension and other postretirement benefit liabilities
 
 
 
266.1

 
268.6

Deferred tax liabilities
 
 
 
17.7

 
17.2

Other long-term liabilities
 
 
 
106.9

 
109.7

Total liabilities
 
 
 
$
4,847.2

 
$
4,580.0

Stockholders’ equity:
 
 
 
 
 
 
Preferred stock, 200.0 million shares authorized at $0.01 par value with no shares issued or outstanding as of June 30, 2017 and December 31, 2016
 
 
 
$

 
$

Common stock, 2.0 billion shares authorized at $0.01 par value with 140.6 million and 138.8 million shares issued and outstanding at June 30, 2017 and December 31, 2016, respectively
 
 
 
1.4

 
1.4

Additional paid-in capital
 
 
 
2,285.1

 
2,251.8

Accumulated deficit
 
 
 
(1,000.0
)
 
(1,053.4
)
Accumulated other comprehensive loss
 
9
 
(326.8
)
 
(389.9
)
Total stockholders’ equity
 
 
 
$
959.7

 
$
809.9

Total liabilities and stockholders’ equity
 
 
 
$
5,806.9

 
$
5,389.9






The accompanying notes are an integral part of these condensed consolidated financial statements.

3

Table of Contents

Univar Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)
 
 
 
 
Six months ended
June 30,
(in millions)
 
Note   
 
2017
 
2016
Operating activities:
 
 
 
 
 
 
Net income
 
 
 
$
53.9

 
$
53.8

Adjustments to reconcile net income to net cash (used) provided by operating activities:
 
 
 
 
 
 
Depreciation and amortization
 
 
 
103.2

 
116.8

Amortization of deferred financing fees and debt discount
 
 
 
3.9

 
4.0

Amortization of pension credit from accumulated other comprehensive loss
 
9
 
(0.1
)
 
(4.5
)
Loss on extinguishment of debt
 
 
 
0.8

 

Deferred income taxes
 
 
 
(5.3
)
 
(3.6
)
Stock-based compensation expense
 
4
 
11.5

 
3.5

Other
 
 
 
0.7

 
(0.4
)
Changes in operating assets and liabilities:
 
 
 
 
 
 
Trade accounts receivable, net
 
 
 
(321.6
)
 
(274.1
)
Inventories
 
 
 
(37.9
)
 
18.3

Prepaid expenses and other current assets
 
 
 
(13.2
)
 
27.7

Trade accounts payable
 
 
 
252.4

 
242.8

Pensions and other postretirement benefit liabilities
 
 
 
(19.2
)
 
(20.2
)
Other, net
 
 
 
(44.8
)
 
(49.0
)
Net cash (used) provided by operating activities
 
 
 
$
(15.7
)
 
$
115.1

Investing activities:
 
 
 
 
 
 
Purchases of property, plant and equipment
 
 
 
$
(38.6
)
 
$
(45.2
)
Purchases of businesses, net of cash acquired
 
 
 
(0.5
)
 
(54.8
)
Proceeds from sale of property, plant and equipment
 
 
 

 
2.9

Other
 
 
 
1.0

 
(1.7
)
Net cash used by investing activities
 
 
 
$
(38.1
)
 
$
(98.8
)
Financing activities:
 
 
 
 
 
 
Proceeds from issuance of long-term debt
 
10
 
$
2,254.0

 
$
20.5

Payments on long-term debt and capital lease obligations
 
10
 
(2,238.0
)
 
(17.3
)
Short-term financing, net
 
10
 
(11.9
)
 
(5.4
)
Financing fees paid
 
 
 
(4.4
)
 

Taxes paid related to net share settlements of stock-based compensation awards
 
 
 
(7.5
)
 

Stock option exercises
 
 
 
28.1

 
0.7

Other
 
 
 
0.5

 
0.3

Net cash provided (used) by financing activities
 
 
 
$
20.8

 
$
(1.2
)
Effect of exchange rate changes on cash and cash equivalents
 
 
 
$
18.4

 
$
20.6

Net (decrease) increase in cash and cash equivalents
 
 
 
(14.6
)
 
35.7

Cash and cash equivalents at beginning of period
 
 
 
336.4

 
188.1

Cash and cash equivalents at end of period
 
 
 
$
321.8

 
$
223.8

Supplemental disclosure of cash flow information:
 
 
 
 
 
 
Non-cash activities:
 
 
 
 
 
 
Additions of property, plant and equipment included in trade accounts payable and other accrued expenses
 
 
 
$
7.5

 
$
6.6

Additions of property, plant and equipment under a capital lease obligation
 
 
 
13.6

 
7.3


The accompanying notes are an integral part of these condensed consolidated financial statements.

4

Table of Contents

Univar Inc.
Condensed Consolidated Statements of Changes in Stockholders' Equity
(Unaudited)
(in millions)
Common
stock
(shares)
 
Common
stock
 
Additional
paid-in
capital
 
Accumulated
deficit
 
Accumulated
other
comprehensive
loss
 
Total
Balance, December 31, 2015
138.0

 
$
1.4

 
$
2,224.7

 
$
(985.0
)
 
$
(424.4
)
 
$
816.7

Net loss

 

 

 
(68.4
)
 

 
(68.4
)
Foreign currency translation adjustment, net of tax $23.9

 

 

 

 
36.3

 
36.3

Pension and other postretirement benefits adjustment, net of tax $1.5

 

 

 

 
(1.8
)
 
(1.8
)
Stock option exercises
0.8

 

 
16.9

 

 

 
16.9

Stock-based compensation

 

 
10.4

 

 

 
10.4

Other



 
(0.2
)
 

 

 
(0.2
)
Balance, December 31, 2016
138.8

 
$
1.4

 
$
2,251.8

 
$
(1,053.4
)

$
(389.9
)
 
$
809.9

Impact due to adoption of ASU, net of tax $0.2 (1)

 

 
0.7

 
(0.5
)
 

 
0.2

Net income

 

 

 
53.9

 

 
53.9

Foreign currency translation adjustment

 

 

 

 
63.2

 
63.2

Pension and other postretirement benefits adjustment, net of tax $0.0

 

 

 

 
(0.1
)
 
(0.1
)
Restricted stock units vested
0.6

 

 

 

 

 

Tax withholdings related to net share settlements of stock-based compensation awards
(0.2
)
 

 
(7.5
)
 

 

 
(7.5
)
Stock option exercises
1.4

 

 
28.1

 

 

 
28.1

Employee stock purchase plan (2)

 

 
0.5

 

 

 
0.5

Stock-based compensation

 

 
11.5

 

 

 
11.5

Balance, June 30, 2017
140.6

 
$
1.4

 
$
2,285.1

 
$
(1,000.0
)
 
$
(326.8
)
 
$
959.7

(1)
Adjusted due to the adoption of ASU 2016-09 “Improvement to Employee Share-Based Payment Accounting” on January 1, 2017. Refer to “ Note 2: Significant accounting policies ” for more information.
(2)
During November 2016, our Board of Directors approved the Univar Employee Stock Purchase Plan, or ESPP, authorizing the issuances of up to  2.0 million  shares of the Company's common stock effective January 1, 2017. The total number of shares issued under the plan for the first offering period from January through June 2017 was approximately 18,000 shares.














The accompanying notes are an integral part of these condensed consolidated financial statements.

5

Table of Contents

Univar Inc.
Notes to Condensed Consolidated Financial Statements
As of June 30, 2017 and
For the Three and Six Month Periods Ended June 30, 2017 and 2016
(Unaudited)

1.
Nature of operations
Headquartered in Downers Grove, Illinois, Univar Inc. (“the Company” or “Univar”) is a leading global chemicals and ingredients distributor and provider of specialty chemicals. The Company’s operations are structured into four operating segments that represent the geographic areas under which the Company manages its business:
Univar USA (“USA”)
Univar Canada (“Canada”)
Univar Europe, the Middle East and Africa (“EMEA”)
Rest of World (“Rest of World”)
Rest of World includes certain developing businesses in Latin America (including Brazil and Mexico) and the Asia-Pacific region.

2 .
Significant accounting policies
Basis of presentation
The condensed consolidated financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) as applicable to interim financial reporting. Unless otherwise indicated, all financial data presented in these condensed consolidated financial statements are expressed in US dollars. These condensed consolidated financial statements, in the Company’s opinion, include all adjustments, consisting of normal recurring accruals necessary for a fair presentation of the condensed consolidated balance sheets, statements of operations, comprehensive income, cash flows and changes in stockholders’ equity. The results of operations for the periods presented are not necessarily indicative of the operating results that may be expected for the full year. These condensed consolidated financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
The condensed consolidated financial statements include the financial statements of the Company and its subsidiaries. Subsidiaries are consolidated if the Company has a controlling financial interest, which may exist based on ownership of a majority of the voting interest, or based on the Company’s determination that it is the primary beneficiary of a variable interest entity (“VIE”) or if otherwise required by US GAAP. The Company did not have any material interests in VIEs during the periods presented in these condensed consolidated financial statements. All intercompany balances and transactions are eliminated in consolidation.
The preparation of condensed consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the amounts reported and disclosed in the financial statements and accompanying notes. Actual results could differ materially from these estimates.
Recently issued and adopted accounting pronouncements
In March 2016, the FASB issued ASU 2016-09 “Compensation – Stock Compensation” (Topic 718) – “Improvement to Employee Share-Based Payment Accounting.” The core principal of the guidance is to simplify several aspects of the accounting for employee share-based payment transactions including the accounting for income taxes, forfeitures, and statutory tax withholding requirements, as well as classification of related amounts within the statement of cash flows. The standard will be effective for fiscal years beginning after December 15, 2016, including interim periods within such fiscal years. The guidance is to be applied using a modified retrospective method by means of a cumulative-effect adjustment to equity as of the beginning of the period in which the guidance is adopted. The Company adopted the ASU as of January 1, 2017 which resulted in an increase of $0.5 million , net of tax $0.2 million in accumulated deficit and the offset of $0.7 million is recorded in additional paid-in capital within condensed consolidated balance sheet and statements of changes in stockholders' equity.
In October 2016, the FASB issued ASU 2016-17 “Consolidation” (Topic 810) - “Interests Held through Related Parties That Are under Common Control.” The core principle of the guidance is to provide amendments to the current consolidation guidance. The revised consolidation guidance modifies how a reporting entity that is a single decision maker of a VIE should treat indirect interests in the entity held through related parties that are under common control with the reporting entity when determining whether it is the primary beneficiary of that VIE. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016. The Company adopted the ASU as of January 1, 2017 and the ASU is applied retrospectively

6


to all relevant prior periods beginning with the fiscal year in which the amendments in ASU 2015-02 “Consolidation” (Topic 810) - “Amendments to the Consolidation Analysis” were applied. The adoption of this ASU had no material impact on the Company’s condensed consolidated financial statements.
Accounting pronouncements issued and not yet adopted
In May 2014, the FASB issued ASU 2014-09 “Revenue from Contracts with Customers” (Topic 606), which supersedes the revenue recognition requirements in Accounting Standards Codification (“ASC”) 605, “Revenue Recognition.” This new revenue standard creates a single source of revenue guidance for all companies in all industries and is more principles-based than the current revenue guidance. The standard will be effective for public entities for interim and annual reporting periods beginning after December 15, 2017. The core principle of the guidance is that “an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.” In achieving this objective, an entity must perform five steps: (1) identify the contract(s) with a customer, (2) identify the performance obligations of the contract, (3) determine the transaction price, (4) allocate the transaction price to the performance obligations in the contract, and (5) recognize revenue when (or as) the entity satisfies a performance obligation. In addition, the standard requires additional new disclosures of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers.
The Company has established a project team who has completed a review of revenue streams and customer contracts to identify and evaluate the potential impacts of the provisions of ASC 606. The Company has accumulated information that will be necessary for implementation disclosures and is assessing the impact the adoption of ASU 2014-09 will have on its consolidated financial statements, related disclosures, and reporting processes. The Company is also in the process of identifying and drafting changes to processes and controls to meet the ASU's updated reporting and disclosure requirements and plans to update its assessment of the impact of the ASU through the date of adoption. Based on the analysis to date, the Company is revising its estimation processes related to arrangements that involve, among other items, potential returns of unused products, as well as revenue deferral where performance to date may have reached right to receive consideration. These changes could impact the timing of revenue recognition between quarters. The Company expects to adopt the new standard using the modified retrospective approach, under which the cumulative effect of initially applying the guidance is recognized as an adjustment to the opening balance of retained earnings in the first quarter of 2018 for contracts that still require performance by the entity, and disclose all line items in the year of adoption as if they were prepared under the old revenue guidance.
In March 2017, the FASB issued ASU 2017-07 “Compensation - Retirement Benefits” (Topic 715) - “Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost.” The ASU requires entities to disaggregate the service cost component from the other components of net periodic benefit costs and present it with other current compensation costs for related employees in the income statement, and present the other component elsewhere in the income statement and outside of income from operations if that subtotal is presented. The amendments in this update also allow only the service cost component to be eligible for capitalization when applicable. The standard will be effective for fiscal years beginning after December 15, 2017, including interim periods within such fiscal years. Early adoption is permitted as of the beginning of an annual period for which financial statements (interim or annual) have not been issued or made available for issuance. The guidance is to be applied retrospectively for all periods presented. The Company is evaluating the impact of the ASU on its consolidated financial statements.
In May 2017, the FASB issued ASU 2017-09 “Compensation - Stock Compensation” (Topic 718) - “Scope of Modification Accounting.” The ASU provides clarity and reduces both diversity in practice and cost and complexity when applying the guidance in Topic 718, Compensation—Stock Compensation, to a change to the terms or conditions of a share-based payment award. The standard will be effective for fiscal years beginning after December 15, 2017, including interim periods within such fiscal years. Early adoption is permitted, including adoption in an interim period. The guidance is to be applied prospectively. The Company is evaluating the impact of the ASU on its consolidated financial statements.
 

7


3.
Employee benefit plans
The following table summarizes the components of net periodic benefit recognized in the condensed consolidated statements of operations:
 
 
 
Domestic - Defined Benefit Pension Plans
 

Three months ended
June 30,

Six months ended
June 30,
(in millions)

2017

2016

2017

2016
Service cost
 
$

 
$

 
$

 
$

Interest cost

7.7


8.0


15.4

 
16.0

Expected return on plan assets

(7.8
)

(8.1
)

(15.5
)
 
(16.2
)
Net periodic benefit

$
(0.1
)

$
(0.1
)

$
(0.1
)

$
(0.2
)

 
 
Foreign - Defined Benefit Pension Plans
 
 
Three months ended
June 30,
 
Six months ended
June 30,
(in millions)
 
2017
 
2016
 
2017
 
2016
Service cost
 
$
0.6

 
$
0.7

 
$
1.2

 
$
1.3

Interest cost
 
4.0

 
4.7

 
7.9

 
9.4

Expected return on plan assets
 
(6.4
)
 
(7.5
)
 
(12.7
)
 
(14.9
)
Net periodic benefit
 
$
(1.8
)
 
$
(2.1
)
 
$
(3.6
)
 
$
(4.2
)

 
 
Other Postretirement Benefits    
 
 
Three months ended
June 30,
 
Six months ended
June 30,
(in millions)
 
2017
 
2016
 
2017
 
2016
Service cost
 
$

 
$

 
$

 
$

Interest cost
 
0.1

 
0.1

 
0.1

 
0.2

Prior service credits
 

 
(1.5
)
 

 
(4.5
)
Net periodic cost (benefit)
 
$
0.1

 
$
(1.4
)
 
$
0.1

 
$
(4.3
)

4 .
Other operating expenses, net
Other operating expenses, net consisted of the following activity:
 
 
Three months ended
June 30,
 
Six months ended
June 30,
(in millions)
 
2017
 
2016
 
2017
 
2016
Acquisition and integration related expenses
 
$
0.5

 
$
2.4

 
$
0.7

 
$
4.3

Stock-based compensation expense
 
5.1

 
1.3

 
11.5

 
3.5

Restructuring charges
 
1.8

 
5.5

 
3.5

 
6.5

Business transformation costs
 
11.5

 

 
20.6

 

Other
 
5.3

 
2.3

 
7.7

 
2.7

Total other operating expenses, net
 
$
24.2

 
$
11.5

 
$
44.0

 
$
17.0




8


5.
Restructuring charges
Restructuring charges relate to the implementation of several regional strategic initiatives aimed at streamlining the Company’s cost structure and improving its operations. These actions primarily resulted in workforce reductions, lease termination costs and other facility rationalization costs. The following table presents cost information related to restructuring plans that have not been completed as of June 30, 2017 and does not contain any estimates for plans that may be developed and implemented in future periods.
(in millions)
 
USA
 
Canada
 
EMEA
 
ROW
 
Other
 
Total
Anticipated total costs
 
 
 
 
 
 
 
 
 
 
 
 
Employee termination costs
 
$
16.8

 
$
5.5

 
$
21.6

 
$
5.1

 
$
5.9

 
$
54.9

Facility exit costs
 
23.5

 

 
3.7

 
0.2

 

 
27.4

Other exit costs
 
1.7

 

 
6.8

 

 
0.8

 
9.3

Total
 
$
42.0

 
$
5.5

 
$
32.1

 
$
5.3

 
$
6.7

 
$
91.6

 
 
 
 
 
 
 
 
 
 
 
 
 
Incurred to date costs
 
 
 
 
 
 
 
 
 
 
 
 
Inception of plans through June 30, 2017
 
 
 
 
 
 
 
 
 
 
 
 
Employee termination costs
 
$
16.8

 
$
5.5

 
$
21.6

 
$
5.1

 
$
5.9

 
$
54.9

Facility exit costs
 
21.8

 

 
3.7

 
0.2

 

 
25.7

Other exit costs
 
1.7

 

 
6.8

 

 
0.8

 
9.3

Total
 
$
40.3

 
$
5.5

 
$
32.1

 
$
5.3

 
$
6.7

 
$
89.9

 
 
 
 
 
 
 
 
 
 
 
 
 
Inception of plans through December 31, 2016
 
 
 
 
 
 
 
 
 
 
 
 
Employee termination costs
 
$
16.8

 
$
5.2

 
$
21.6

 
$
4.4

 
$
5.8

 
$
53.8

Facility exit costs
 
19.6

 

 
3.5

 
0.2

 

 
23.3

Other exit costs
 
1.7

 

 
6.8

 

 
0.8

 
9.3

Total
 
$
38.1

 
$
5.2

 
$
31.9

 
$
4.6

 
$
6.6

 
$
86.4


The following table summarizes activity related to accrued liabilities associated with restructuring:
(in millions)
 
January 1, 2017
 
Charge to  
earnings
 
Cash    
paid
 
Non-cash    
and other
 
June 30, 2017
Employee termination costs
 
$
6.9

 
$
1.0

 
$
(4.0
)
 
$
0.3

 
$
4.2

Facility exit costs
 
13.2

 
2.5

 
(3.5
)
 

 
12.2

Other exit costs
 

 

 

 

 

Total
 
$
20.1

 
$
3.5

 
$
(7.5
)
 
$
0.3

 
$
16.4


(in millions)
 
January 1, 2016
 
Charge to  
earnings
 
Cash    
paid
 
Non-cash    
and other
 
December 31, 2016
Employee termination costs
 
$
31.0

 
$
0.4

 
$
(24.5
)
 
$

 
$
6.9

Facility exit costs
 
15.5

 
6.0

 
(8.3
)
 

 
13.2

Other exit costs
 
0.1

 
0.1

 
(0.2
)
 

 

Total
 
$
46.6

 
$
6.5

 
$
(33.0
)
 
$

 
$
20.1


Restructuring liabilities of $7.4 million and $10.1 million were classified as current in other accrued expenses in the condensed consolidated balance sheets as of June 30, 2017 and December 31, 2016 , respectively. The long-term portion of restructuring liabilities of $9.0 million and $10.0 million were recorded in other long-term liabilities in the condensed consolidated balance sheets as of June 30, 2017 and December 31, 2016 , respectively, and primarily consists of facility exit costs that are expected to be paid within the next four years .
While the Company believes the recorded restructuring liabilities are adequate, revisions to current estimates may be recorded in future periods based on new information as it becomes available.

9


6.
Other (expense) income, net
Other (expense) income, net consisted of the following gains (losses):
 
 
Three months ended
June 30,
 
Six months ended
June 30,
(in millions)
 
2017

2016
 
2017
 
2016
Foreign currency transactions
 
$
(1.8
)

$
0.3

 
$
(3.9
)
 
$
(2.4
)
Foreign currency denominated loans revaluation
 
(5.4
)

5.4

 
(8.4
)
 
(9.3
)
Undesignated foreign currency derivative instruments (1)
 
1.2


(0.9
)
 
2.2

 
1.0

  Undesignated interest rate swap contracts (1)
 
(4.8
)

1.5

 
(4.8
)
 
2.2

Debt amendment costs (2)
 



 
(4.2
)
 

Other
 
(0.9
)

(0.6
)
 
(1.7
)
 
0.8

Total other (expense) income, net
 
$
(11.7
)
 
$
5.7

 
$
(20.8
)
 
$
(7.7
)
 
(1)
Refer to “ Note 13: Derivatives ” for more information.
(2)
Refer to “ Note 10: Debt ” for more information.

7.
Income taxes
The Company’s tax provision for interim periods is determined using an estimate of the annual effective tax rate, adjusted for discrete items, if any, that are taken into account in the relevant period. Each quarter, an estimate of the annual effective tax rate is updated should management revise its forecast of earnings based upon the Company’s operating results. If there is a change in the estimated effective annual tax rate, a cumulative adjustment is made. The quarterly tax provision and forecast estimate of the annual effective tax rate may be subject to volatility due to several factors, including the complexity in forecasting jurisdictional earnings before tax, the rate of realization of forecasting earnings or losses by quarter, acquisitions, divestitures, foreign currency gains and losses, pension gains and losses, etc.
The income tax expense for the three and six months ended June 30, 2017 was $7.3 million and $8.9 million , resulting in an effective tax rate of 18.9% and 14.2% , respectively. The Company’s effective tax rate for the three month and six month periods ended June 30, 2017 was lower than the US federal statutory rate of 35.0% primarily due to the mix of earnings in multiple jurisdictions, non-taxable interest income and the release of a valuation allowance on certain foreign tax attributes. Included in the $7.3 million and $8.9 million expense for the three and six months ended June 30, 2017 was a $1.3 million and $3.5 million benefit, respectively, related to excess tax benefits from share-based compensation.
The income tax expense for the three and six months ended June 30, 2016 was $0.9 million and $6.0 million , resulting in an effective tax rate of 2.2% and 10.0% , respectively. The Company’s effective tax rate for three months ended June 30, 2016 was lower than the US federal statutory rate of 35.0% primarily due to the mix of earnings in multiple jurisdictions, non-taxable interest income and the release of a valuation allowance on certain foreign tax attributes. The Company's effective tax rate for the six months ended June 30, 2016 was lower than the US federal statutory rate primarily due to the mix of earnings in multiple jurisdictions, non-taxable interest income and the release of a valuation allowance on certain foreign tax attributes.
Canadian General Anti-Avoidance Rule matters
In 2007, the outstanding shares of Univar N.V., the ultimate public company parent of the Univar group at that time, were acquired by investment funds advised by CVC. To facilitate the acquisition and leveraged financing of Univar N.V. by CVC, a restructuring of some of the companies in the Univar group, including its Canadian operating company, was completed (the “Restructuring”). In February 2013, the Canada Revenue Agency (“CRA”) issued a Notice of Assessment, asserting the General Anti-Avoidance Rule (“GAAR”) against the Company’s subsidiary Univar Holdco Canada ULC (“Univar Holdco”) for withholding tax of $29.4 million (Canadian), relating to this Restructuring. Univar Holdco appealed the assessment, and the matter was litigated in the Tax Court of Canada in June 2015. On June 22, 2016, the Tax Court of Canada issued its judgment in favor of the CRA. The Company subsequently appealed the judgment and a trial in the Federal Court of Canada occurred on May 10, 2017. The Company has not yet received the Federal Court of Canada's decision on the matter. A $52.1 million (Canadian) Letter of Credit, covering the initial assessment of $29.4 million (Canadian) and interest of $22.7 million (Canadian), has been issued with respect to this assessment.
In September 2014, also relating to the Restructuring, the CRA issued the 2008 and 2009 Notice of Reassessments for federal corporate income tax liabilities of $11.9 million (Canadian) and $11.0 million (Canadian), respectively, and a departure tax liability of $9.0 million (Canadian). Likewise, in April 2015, the Company’s subsidiary received the 2008 and 2009 Alberta Notice of Reassessments of $6.0 million (Canadian) and $5.8 million (Canadian), respectively. These Reassessments reflect the additional tax liability and interest relating to those tax years should the CRA be successful in its assertion of the GAAR relating to the

10


Restructuring described above. In accordance with the CRA's collection procedures, a $21.0 million (Canadian) Letter of Credit has been issued with respect to the federal assessment.
At June 30, 2017 , the total Canadian federal and provincial tax liability assessed related to these matters, inclusive of interest of $41.5 million (Canadian), is $114.6 million (Canadian). The Company has not recorded any liabilities for these matters in its financial statements, as it believes it is more likely than not that the ruling will be reversed on appeal and the Company’s position will be sustained, along with the release of all Letters of Credit currently provided to the CRA.

8.
Earnings per share
The following table presents the basic and diluted earnings per share computations:
 
 
Three months ended June 30,
 
Six months ended June 30,
(in millions, except per share data)
 
2017
 
2016
 
2017
 
2016
Basic:
 
 
 
 
 
 
 
 
Net income
 
$
31.3

 
$
39.8

 
$
53.9

 
$
53.8

Less: Earnings Allocated to Participating Securities
 
0.1

 

 
0.1

 

Earnings Allocated to Common Shares Outstanding
 
$
31.2

 
$
39.8

 
$
53.8

 
$
53.8

Weighted average common shares outstanding
 
140.1

 
137.6

 
139.8

 
137.6

Basic income per common share
 
$
0.22

 
$
0.29

 
$
0.38

 
$
0.39

Diluted:
 
 
 
 
 
 
 
 
Net income
 
$
31.3

 
$
39.8

 
$
53.9

 
$
53.8

Less: Earnings Allocated to Participating Securities
 

 

 

 

Earnings Allocated to Common Shares Outstanding
 
$
31.3

 
$
39.8

 
$
53.9

 
$
53.8

Weighted average common shares outstanding
 
140.1

 
137.6

 
139.8

 
137.6

Effect of dilutive securities: Stock compensation plans (1)
 
1.2

 
0.5

 
1.4

 
0.4

Weighted average common shares outstanding – diluted
 
141.3

 
138.1

 
141.2

 
138.0

Diluted income per common share
 
$
0.22

 
$
0.29

 
$
0.38

 
$
0.39

 
   
(1)
Stock options to purchase 0.9 million and 3.9 million shares of common stock were outstanding during the three months ended June 30, 2017 and 2016 , respectively, but were not included in the calculation of diluted income per share as the impact of these stock options would have been anti-dilutive. Stock options to purchase 0.8 million and 4.2 million shares of common stock were outstanding during the six months ended June 30, 2017 and 2016 , respectively, but were not included in the calculation of diluted income per share as the impact of these stock options would have been anti-dilutive.


11


9.
Accumulated other comprehensive loss
The following tables present the changes in accumulated other comprehensive loss by component, net of tax:
(in millions)
 
Defined
benefit
pension items
 
Currency
translation
items
 
Total
Balance as of December 31, 2016
 
$
1.2

 
$
(391.1
)
 
$
(389.9
)
Other comprehensive income before reclassifications
 

 
63.2

 
63.2

        Amounts reclassified from accumulated other comprehensive loss
 
(0.1
)
 

 
(0.1
)
Net current period other comprehensive (loss) income
 
$
(0.1
)
 
$
63.2

 
$
63.1

Balance as of June 30, 2017
 
$
1.1

 
$
(327.9
)
 
$
(326.8
)
 
 
 
 
 
 
 
Balance as of December 31, 2015
 
$
3.0

 
$
(427.4
)
 
$
(424.4
)
Other comprehensive income before reclassifications
 

 
66.7

 
66.7

Amounts reclassified from accumulated other comprehensive loss
 
(3.0
)
 

 
(3.0
)
Net current period other comprehensive (loss) income
 
$
(3.0
)
 
$
66.7

 
$
63.7

Balance as of June 30, 2016
 
$

 
$
(360.7
)
 
$
(360.7
)

The following is a summary of the amounts reclassified from accumulated other comprehensive loss to net income:
 
 
Three months ended June 30,
 
 
(in millions)
 
2017 (1)
 
2016 (1)
 
Location of impact on
  statement of operations  
Amortization of defined benefit pension items:
 
 
 
 
 
 
Prior service credits
 
$
(0.1
)
 
$
(1.5
)
 
Warehousing, selling and administrative
Tax expense
 

 
0.3

 
Income tax expense
Net of tax
 
$
(0.1
)
 
$
(1.2
)
 
 
Total reclassifications for the period
 
$
(0.1
)
 
$
(1.2
)
 
 

 
 
Six months ended June 30,
 
 
(in millions)
 
2017 (1)
 
2016 (1)
 
Location of impact on
  statement of operations  
Amortization of defined benefit pension items:
 
 
 
 
 
 
Prior service credits
 
$
(0.1
)
 
$
(4.5
)
 
Warehousing, selling and administrative
Tax expense
 

 
1.5

 
Income tax expense
Net of tax
 
$
(0.1
)
 
$
(3.0
)
 
 
Total reclassifications for the period
 
$
(0.1
)
 
$
(3.0
)
 
 
 
 
(1)
Amounts in parentheses indicate credits to net income in the condensed consolidated statement of operations.
Refer to “ Note 3: Employee benefit plans ” for additional information regarding the amortization of defined benefit pension items.
Foreign currency gains and losses relating to intercompany borrowings that are considered a part of the Company’s investment in a foreign subsidiary are reflected in accumulated other comprehensive loss. There were no foreign currency gains and losses related to such intercompany borrowings for the three month period ended June 30, 2017 and there were $15.5 million in total foreign currency losses for the three month period ended June 30, 2016 . Total foreign currency gains and losses related to such intercompany borrowings were $0.5 million in gains and $ 20.0 million in losses for the six month periods ended June 30, 2017 and 2016 , respectively.






12


10.
Debt
Short-term financing
Short-term financing consisted of the following:
(in millions)
 
June 30, 2017
 
December 31, 2016
Amounts drawn under credit facilities
 
$
10.4

 
$
12.1

Bank overdrafts
 
9.0

 
13.2

Total short-term financing
 
$
19.4

 
$
25.3

As of June 30, 2017 and December 31, 2016 , the Company had $179.4 million and $175.3 million in outstanding letters of credit and guarantees, respectively.
Long-term debt
Long-term debt consisted of the following:
(in millions)
 
June 30, 2017
 
December 31, 2016
Senior Term Loan Facilities:




Term B Loan Due 2022, variable interest rate of 3.98% and 4.25% at June 30, 2017 and December 31, 2016, respectively

$
2,189.0


$
2,024.4

Euro Tranche Term Loan Due 2022, variable interest rate of 4.25% at June 30, 2017 and December 31, 2016

93.1


259.9

Asset Backed Loan (ABL) Facilities:




North American ABL Facility Due 2020, variable interest rate of 2.97% and 4.25% at June 30, 2017 and December 31, 2016, respectively

222.5


152.0

North American ABL Term Loan Due 2018, variable interest rate of 4.05% and 3.75% at June 30, 2017 and December 31, 2016, respectively

50.0


83.3

Senior Unsecured Notes:




Senior Unsecured Notes due 2023, fixed interest rate of 6.75% at June 30, 2017 and December 31, 2016

399.5


399.5

Capital lease obligations

66.1


63.4

Total long-term debt before discount

$
3,020.2


$
2,982.5

Less: unamortized debt issuance costs and discount on debt

(25.4
)

(28.5
)
Total long-term debt

$
2,994.8


$
2,954.0

Less: current maturities

(99.3
)

(109.0
)
Total long-term debt, excluding current maturities

$
2,895.5


$
2,845.0


The weighted average interest rate on long-term debt was 4.60% and 4.84% as of June 30, 2017 and December 31, 2016 , respectively.
On January 19, 2017, Univar USA Inc. entered into an amended Term B loan agreement which replaced the existing US dollar denominated loans with new US dollar denominated loans in aggregate of $2.2 billion . The amendment also reduced the interest rate credit spread on the US dollar denominated loans by 50 basis points from 3.25% to 2.75% and removed the 1.00% LIBOR floor. The additional proceeds of $175.6 million received from the US dollar denominated loans were used to prepay a portion of the existing Euro denominated Term B Loans.
As a result of this debt amendment, the Company recognized debt refinancing costs of $4.2 million in other (expense) income, net in the condensed consolidated statements of operations during the six months ended June 30, 2017. Refer to “ Note 6: Other (expense) income, net ” for further information. In addition, the Company recognized a loss on extinguishment of debt of $0.8 million in the six months ended June 30, 2017.

13


11.
Supplemental balance sheet information
Property, plant and equipment, net
(in millions)
 
June 30, 2017
 
December 31, 2016
Property, plant and equipment, at cost
 
$
1,887.6

 
$
1,831.0

Less: accumulated depreciation
 
(878.8
)
 
(811.5
)
Property, plant and equipment, net
 
$
1,008.8

 
$
1,019.5

Capital lease assets, net
Included within property, plant and equipment, net are assets related to capital leases where the Company is the lessee. The below table summarizes the cost and accumulated depreciation related to these assets:
(in millions)
 
June 30, 2017
 
December 31, 2016
Capital lease assets, at cost
 
$
84.9

 
$
76.5

Less: accumulated depreciation
 
(20.7
)
 
(14.5
)
Capital lease assets, net
 
$
64.2

 
$
62.0

Intangible assets, net
The gross carrying amounts and accumulated amortization of the Company’s intangible assets were as follows:
 
 
June 30, 2017
 
December 31, 2016
(in millions)
 
Gross
 
Accumulated
Amortization
 
Net
 
Gross
 
Accumulated
Amortization
 
Net
Intangible assets:
 
 
 
 
 
 
 
 
 
 
 
 
Customer relationships
 
$
843.4

 
$
(550.1
)
 
$
293.3

 
$
826.2

 
$
(514.3
)
 
$
311.9

Other
 
176.4

 
(157.0
)
 
19.4

 
178.2

 
(150.9
)
 
27.3

Total intangible assets
 
$
1,019.8

 
$
(707.1
)
 
$
312.7

 
$
1,004.4

 
$
(665.2
)
 
$
339.2

Other intangible assets consist of intellectual property trademarks, trade names, supplier relationships, non-compete agreements and exclusive distribution rights.
Other accrued expenses    
As of June 30, 2017, there were no other accrued expenses that were greater than five percent of total current liabilities. As of December 31, 2016 , other accrued expenses that were greater than five percent of total current liabilities consisted of customer prepayments and deposits, which were $84.6 million .

12.    Fair value measurements
Items measured at fair value on a recurring basis
The following table presents the Company’s gross assets and liabilities measured on a recurring basis:
 
 
Level 2
 
Level 3
(in millions)
 
June 30, 2017
 
December 31, 2016
 
June 30, 2017
 
December 31, 2016
Financial current assets:
 
 
 
 
 
 
 
 
Forward currency contracts
 
$
0.4

 
$
0.5

 
$

 
$

Financial noncurrent assets:
 
 
 
 
 
 
 
 
Interest rate swap contracts
 
3.5

 
9.8

 

 

Financial current liabilities:
 
 
 
 
 
 
 
 
Forward currency contracts
 
0.5

 
0.3

 

 

Interest rate swap contracts
 
5.5

 
5.6

 

 

Contingent consideration
 

 

 
0.4

 
1.6

Financial noncurrent liabilities:
 
 
 
 
 
 
 
 
Contingent consideration
 

 

 
0.5

 
5.9


14


The net amounts related to forward currency contracts included in prepaid and other current assets were $0.2 million and $0.5 million as of June 30, 2017 and December 31, 2016 , respectively. The net amounts related to foreign currency contracts included in other accrued expenses were $0.3 million as of June 30, 2017 and December 31, 2016 .
The fair value of forward currency contracts is calculated by reference to current forward exchange rates for contracts with similar maturity profiles. The fair value of interest rate swaps is determined by estimating the net present value of amounts to be paid under the agreement offset by the net present value of the expected cash inflows based on market rates and associated yield curves. Based on these valuation methodologies, these derivative contracts are classified as level 2 in the fair value hierarchy.
The fair value of the contingent consideration is based on a real options approach, which took into account management’s best estimate of the acquiree’s performance, as well as achievement risk. Based on the valuation methodology, contingent consideration is classified as level 3 in the fair value hierarchy.
The following table is a reconciliation of the fair value measurements that use significant unobservable inputs (Level 3), which consists of contingent consideration related to prior acquisitions.
(in millions)
 
Contingent
  consideration  
Fair value as of December 31, 2016
 
$
7.5

Fair value adjustments
 
(2.5
)
Payments
 
(3.2
)
Gain on settlement
 
(0.9
)
Fair value as of June 30, 2017
 
$
0.9

The change in the fair value and payments related to the contingent consideration are recorded in the other, net line item of the operating activities within the condensed consolidated statement of cash flows.
Financial instruments not carried at fair value
The estimated fair value of financial instruments not carried at fair value in the condensed consolidated balance sheets were as follows:
 
 
June 30, 2017
 
December 31, 2016
(in millions)
 
Carrying    
Amount
 
Fair
Value    
 
Carrying    
Amount
 
Fair
Value    
Financial liabilities:
 
 
 
 
 
 
 
 
Long-term debt including current portion (Level 2)
 
$
2,994.8

 
$
3,045.0

 
$
2,954.0

 
$
3,019.1

The fair values of the long-term debt, including the current portions, were based on current market quotes for similar borrowings and credit risk adjusted for liquidity, margins and amortization, as necessary.
Fair value of other financial instruments
The carrying value of cash and cash equivalents, trade accounts receivable, net, trade accounts payable and short-term financing included in the condensed consolidated balance sheets approximate fair value due to their short-term nature.

13.    Derivatives
Interest rate swaps
The objective of the interest rate swap contracts is to offset the variability of cash flows in LIBOR indexed debt interest payments attributable to changes in the aforementioned benchmark interest rate related to the Term B Loan due 2022.
At June 30, 2017 , the Company had interest rate swap contracts with a total notional amount of $2.0 billion whereby a fixed rate of interest (weighted-average of 1.70% ) is paid and a variable rate of interest (three-month LIBOR) is received on the notional amount. The Company does not currently apply hedge accounting for the interest rate swap contracts, which will expire on June 30, 2020. The interest rate swap contracts initially included a LIBOR floor of 1.00% , which was removed on February 1, 2017, as part of the amendment to the interest rate swap contracts. The contracts were amended as a result of the amendment of Senior Term B loan agreement with US dollar denominated tranche on January 19, 2017. Refer to “ Note 10: Debt ” for additional information. As a result of the interest rate swap contracts amendment, the Company realized a gain of $1.4 million in other (expense) income, net in the condensed consolidated statement of operations. Changes in fair value of the interest rate swap contracts are also recognized directly in other (expense) income, net in the condensed consolidated statement of operations. Refer to “ Note 6: Other (expense) income, net ” for additional information.

15


The fair value of interest rate swaps is recorded either in prepaids and other current assets, other assets, other accrued expenses or other long-term liabilities in the condensed consolidated balance sheets. As of June 30, 2017 and December 31, 2016 , a current liability of $5.5 million and $5.6 million was included in other accrued expenses, respectively. As of June 30, 2017 and December 31, 2016 , a noncurrent asset of $3.5 million and $9.8 million was included in other assets, respectively.
The Company had interest rate swap contracts with a total notional amount of $1.0 billion which expired during June 2017.
Interest rate caps
The Company had interest rate caps with a notional amount of $800.0 million which expired during June 2017. As of June 30, 2017 , the interest rate cap premiums have been fully amortized through interest expense within the condensed consolidated statements of operations.
Foreign currency derivatives
The Company uses forward currency contracts to hedge earnings from the effects of foreign exchange relating to certain of the Company’s intercompany and third-party receivables and payables denominated in a foreign currency. These derivative instruments are not formally designated as hedges by the Company and the terms of these instruments range from one to three months. Forward currency contracts are recorded at fair value in either prepaid expenses and other current assets or other accrued expenses in the condensed consolidated balance sheet, reflecting their short-term nature. The fair value adjustments and gains and losses are included in other (expense) income, net within the condensed consolidated statements of operations. Refer to “ Note 6: Other (expense) income, net ” for more information. The total notional amount of undesignated forward currency contracts were $98.2 million and $111.0 million as of June 30, 2017 and December 31, 2016 , respectively.
Cash flows associated with derivative financial instruments are recognized in the operating section of the condensed consolidated statement of cash flows.

14.
Commitments and Contingencies
Litigation
In the ordinary course of business the Company is subject to pending or threatened claims, lawsuits, regulatory matters and administrative proceedings from time to time. Where appropriate the Company has recorded provisions in the condensed consolidated financial statements for these matters. The liabilities for injuries to persons or property are in some instances covered by liability insurance, subject to various deductibles and self-insured retentions.
The Company is not aware of any claims, lawsuits, regulatory matters or administrative proceedings, pending or threatened, that are likely to have a material effect on its overall financial position, results of operations or cash flows. However, the Company cannot predict the outcome of any claims or litigation or the potential for future claims or litigation.
The Company is subject to liabilities from claims alleging personal injury from exposure to asbestos. The claims result primarily from an indemnification obligation related to Univar USA Inc.’s 1986 purchase of McKesson Chemical Company from McKesson Corporation (“McKesson”). Univar USA is also a defendant in a small number of asbestos claims. As of June 30, 2017 , there were fewer than 278 asbestos-related claims for which the Company has liability for defense and indemnity pursuant to the indemnification obligation. The volume of such cases has decreased in recent quarters. Historically, the vast majority of the claims against both McKesson and Univar USA have been dismissed without payment. The Company does incur costs in defending these claims. While the Company is unable to predict the outcome of these matters, it does not believe, based upon currently available facts, that the ultimate resolution of any of these matters will have a material effect on its overall financial position, results of operations or cash flows. However, the Company cannot predict the outcome of any present or future claims or litigation and adverse developments could negatively impact earnings or cash flows in a particular future period.
Environmental
The Company is subject to various federal, state and local environmental laws and regulations that require environmental assessment or remediation efforts (collectively “environmental remediation work”) at approximately 129 locations, some that are now or were previously Company-owned/occupied and some that were never Company-owned/occupied (“non-owned sites”).
The Company’s environmental remediation work at some sites is being conducted pursuant to governmental proceedings or investigations. At other sites, the Company, with appropriate state or federal agency oversight and approval, is conducting the environmental remediation work voluntarily. The Company is currently undergoing remediation efforts or is in the process of active review of the need for potential remediation efforts at approximately 106 current or formerly Company-owned/occupied sites. In addition, the Company may be liable for a share of the clean-up of approximately 23 non-owned sites. These non-owned sites are typically (a) locations of independent waste disposal or recycling operations with alleged or confirmed contaminated soil and/or groundwater to which the Company may have shipped waste products or drums for re-conditioning, or (b) contaminated

16


non-owned sites near historical sites owned or operated by the Company or its predecessors from which contamination is alleged to have arisen.
In determining the appropriate level of environmental reserves, the Company considers several factors such as information obtained from investigatory studies; changes in the scope of remediation; the interpretation, application and enforcement of laws and regulations; changes in the costs of remediation programs; the development of alternative cleanup technologies and methods; and the relative level of the Company’s involvement at various sites for which the Company is allegedly associated. The level of annual expenditures for remedial, monitoring and investigatory activities will change in the future as major components of planned remediation activities are completed and the scope, timing and costs of existing activities are changed. Project lives, and therefore cash flows, range from 2 to 30 years , depending on the specific site and type of remediation project.
Although the Company believes that its reserves are adequate for environmental contingencies, it is possible due to the uncertainties noted above; that additional reserves could be required in the future that could have a material effect on the overall financial position, results of operations, or cash flows in a particular period. This additional loss or range of losses cannot be recorded at this time, as it is not reasonably estimable.
Changes in total environmental liabilities are as follows:
 
 
Six months ended June 30,
(in millions)
 
2017
 
2016
Environmental liabilities at beginning of period
 
$
95.8

 
$
113.2

Revised obligation estimates
 
6.9

 
5.1

Environmental payments
 
(10.0
)
 
(9.7
)
Foreign exchange
 
0.3

 
(0.1
)
Environmental liabilities at end of period
 
$
93.0

 
$
108.5

Environmental liabilities of $29.0 million and $30.2 million were classified as current in other accrued expenses in the condensed consolidated balance sheets as of June 30, 2017 and December 31, 2016 , respectively. The long-term portion of environmental liabilities is recorded in other long-term liabilities in the condensed consolidated balance sheets.
Customs and International Trade Laws
In April 2012, the US Department of Justice (“DOJ”) issued a civil investigative demand to the Company in connection with an investigation into the Company’s compliance with applicable customs and international trade laws and regulations relating to the importation of saccharin from 2002 through 2012. The Company also became aware in 2010 of an investigation being conducted by US Customs and Border Patrol (“CBP”) into the Company’s importation of saccharin. Finally, the Company learned that a civil plaintiff had sued the Company and two other defendants in a Qui Tam proceeding, such filing having been made under seal in 2012, and this plaintiff had requested that the DOJ intervene in its lawsuit.
The US government, through the DOJ, declined to intervene in the Qui Tam proceeding in November 2013 and, as a result, the DOJ’s inquiry related to the Qui Tam lawsuit and its initial investigation demand are now finished. On February 26, 2014, the Qui Tam plaintiff also voluntarily dismissed its lawsuit against the Company.
CBP, however, continued its investigation on the importation of saccharin by the Company’s subsidiary, Univar USA Inc. On July 21, 2014, CBP sent the Company a “Pre-Penalty Notice” indicating the imposition of a penalty against Univar USA Inc. in the amount of approximately $84.0 million . Univar USA Inc. responded to CBP that the proposed penalty was not justified. On October 1, 2014, the CBP issued a penalty notice to Univar USA Inc. for $84.0 million and has reaffirmed this penalty notice. On August 6, 2015, the DOJ filed a complaint on CBP’s behalf against Univar USA Inc. in the Court of International Trade seeking approximately $84.0 million in allegedly unpaid duties, penalties, interest, costs and attorneys’ fees. Discovery is underway in this matter. The Company continues to defend this matter vigorously. Univar USA Inc. has not recorded a liability related to this investigation as the Company believes a loss is not probable. Although the Company believes its position is strong it cannot guarantee the outcome of this or other litigation.

15.     Segments
Management monitors the operating results of its operating segments separately for the purpose of making decisions about resource allocation and performance assessment. Management evaluates performance on the basis of Adjusted EBITDA. Adjusted EBITDA is defined as consolidated net income, plus the sum of: interest expense, net of interest income; income tax expense; depreciation; amortization; impairment charges; other operating expenses, net; and other (expense) income, net.
Transfer prices between operating segments are set on an arms-length basis in a similar manner to transactions with third parties. Corporate operating expenses that directly benefit segments have been allocated to the operating segments. Allocable

17


operating expenses are identified through a review process by management. These costs are allocated to the operating segments on a basis that reasonably approximates the use of services. This is typically measured on a weighted distribution of margin, asset, headcount or time spent.
Other/Eliminations represents the elimination of inter-segment transactions as well as unallocated corporate costs consisting of costs specifically related to parent company operations that do not directly benefit segments, either individually or collectively.
Financial information for the Company’s segments is as follows:
(in millions)

USA

Canada

EMEA

Rest of
World

Other/
Eliminations
(1)

Consolidated
 

Three Months Ended June 30, 2017
Net sales:












External customers

$
1,191.1


$
492.4


$
463.7


$
99.8


$

 
$
2,247.0

Inter-segment

35.0


2.3


1.2


0.2


(38.7
)
 

Total net sales

$
1,226.1


$
494.7


$
464.9


$
100.0


$
(38.7
)
 
$
2,247.0

Cost of goods sold

950.4


427.2


360.2


81.5


(38.7
)
 
1,780.6

Gross profit

$
275.7


$
67.5


$
104.7


$
18.5


$

 
$
466.4

Outbound freight and handling

47.3


9.2


13.8


1.6



 
71.9

Warehousing, selling and administrative

136.4


21.5


54.6


12.0


9.1

 
233.6

Adjusted EBITDA

$
92.0


$
36.8


$
36.3


$
4.9


$
(9.1
)
 
$
160.9

Other operating expenses, net

 
 
 
 
 
 
 
 
 
 
24.2

Depreciation

 
 
 
 
 
 
 
 
 
 
34.1

Amortization

 
 
 
 
 
 
 
 
 
 
16.5

Interest expense, net

 
 
 
 
 
 
 
 
 
 
35.8

Other expense, net

 
 
 
 
 
 
 
 
 
 
11.7

Income tax expense

 
 
 
 
 
 
 
 
 
 
7.3

Net income

 
 
 
 
 
 
 
 
 
 
$
31.3

Total assets

$
3,643.1

 
$
2,129.5

 
$
972.2

 
$
223.7

 
$
(1,161.6
)
 
$
5,806.9


(in millions)

USA

Canada

EMEA

Rest of
World

Other/
Eliminations
(1)

Consolidated
 

Three Months Ended June 30, 2016
Net sales:












External customers

$
1,212.8

 
$
485.4

 
$
459.9

 
$
104.4

 
$

 
$
2,262.5

Inter-segment

25.0

 
1.7

 
1.0

 

 
(27.7
)
 

Total net sales

$
1,237.8

 
$
487.1

 
$
460.9

 
$
104.4

 
$
(27.7
)
 
$
2,262.5

Cost of goods sold

974.7

 
426.5

 
357.8

 
85.8

 
(27.7
)
 
1,817.1

Gross profit

$
263.1

 
$
60.6

 
$
103.1

 
$
18.6

 
$

 
$
445.4

Outbound freight and handling

48.2

 
8.4

 
14.8

 
1.9

 

 
73.3

Warehousing, selling and administrative

131.7

 
20.7

 
55.3

 
12.5

 
3.7

 
223.9

Adjusted EBITDA

$
83.2

 
$
31.5

 
$
33.0

 
$
4.2

 
$
(3.7
)
 
$
148.2

Other operating expenses, net

 
 
 
 
 
 
 
 
 
 
11.5

Depreciation

 
 
 
 
 
 
 
 
 
 
38.0

Amortization

 
 
 
 
 
 
 
 
 
 
23.3

Interest expense, net

 
 
 
 
 
 
 
 
 
 
40.4

Other income, net

 
 
 
 
 
 
 
 
 
 
(5.7
)
Income tax expense

 
 
 
 
 
 
 
 
 
 
0.9

Net income











$
39.8

Total assets

$
4,012.8

 
$
1,997.8

 
$
990.3

 
$
242.7

 
$
(1,289.2
)
 
$
5,954.4



18



(in millions)
 
USA
 
Canada
 
EMEA
 
Rest of
World
 
Other/
Eliminations (1)
 
Consolidated
 
 
Six Months Ended June 30, 2017
Net sales:
 
 
 
 
 
 
 
 
 
 
 
 
External customers
 
$
2,342.0

 
$
799.7

 
$
903.4

 
$
200.7

 
$

 
$
4,245.8

Inter-segment
 
66.2

 
4.1

 
2.5

 
0.3

 
(73.1
)
 

Total net sales
 
$
2,408.2

 
$
803.8

 
$
905.9

 
$
201.0

 
$
(73.1
)
 
$
4,245.8

Cost of goods sold
 
1,869.6

 
680.5

 
699.4

 
163.6

 
(73.1
)
 
3,340.0

Gross profit
 
$
538.6

 
$
123.3

 
$
206.5

 
$
37.4

 
$

 
$
905.8

Outbound freight and handling
 
94.1

 
18.4

 
27.2

 
3.2

 

 
142.9

Warehousing, selling and administrative
 
270.8

 
43.3

 
107.1

 
22.6

 
15.9

 
459.7

Adjusted EBITDA
 
$
173.7

 
$
61.6

 
$
72.2

 
$
11.6

 
$
(15.9
)
 
$
303.2

Other operating expenses, net
 
 
 
 
 
 
 
 
 
 
 
44.0

Depreciation
 
 
 
 
 
 
 
 
 
 
 
70.0

Amortization
 
 
 
 
 
 
 
 
 
 
 
33.2

Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
71.6

Loss on extinguishment of debt
 
 
 
 
 
 
 
 
 
 
 
0.8

Other expense, net
 
 
 
 
 
 
 
 
 
 
 
20.8

Income tax expense
 
 
 
 
 
 
 
 
 
 
 
8.9

Net income
 
 
 
 
 
 
 
 
 
 
 
$
53.9

Total assets
 
$
3,643.1

 
$
2,129.5

 
$
972.2

 
$
223.7

 
$
(1,161.6
)
 
$
5,806.9


(in millions)
 
USA
 
Canada
 
EMEA
 
Rest of
World
 
Other/
Eliminations (1)
 
Consolidated
 
 
Six Months Ended June 30, 2016
Net sales:
 
 
 
 
 
 
 
 
 
 
 
 
External customers
 
$
2,400.3

 
$
758.1

 
$
897.3

 
$
205.8

 
$

 
$
4,261.5

Inter-segment
 
51.9

 
4.0

 
2.4

 

 
(58.3
)
 

Total net sales
 
$
2,452.2

 
$
762.1

 
$
899.7

 
$
205.8

 
$
(58.3
)
 
$
4,261.5

Cost of goods sold
 
1,926.2

 
650.9

 
700.4

 
166.6

 
(58.3
)
 
3,385.8

Gross profit
 
$
526.0

 
$
111.2

 
$
199.3

 
$
39.2

 
$

 
$
875.7

Outbound freight and handling
 
95.9

 
16.2

 
28.8

 
3.7

 

 
144.6

Warehousing, selling and administrative
 
266.1

 
41.8

 
109.2

 
23.4

 
8.3

 
448.8

Adjusted EBITDA
 
$
164.0

 
$
53.2

 
$
61.3

 
$
12.1

 
$
(8.3
)
 
$
282.3

Other operating expenses, net
 
 
 
 
 
 
 
 
 
 
 
17.0

Depreciation
 
 
 
 
 
 
 
 
 
 
 
71.5

Amortization
 
 
 
 
 
 
 
 
 
 
 
45.3

Interest expense, net
 
 
 
 
 
 
 
 
 
 
 
81.0

Other expense, net
 
 
 
 
 
 
 
 
 
 
 
7.7

Income tax expense
 
 
 
 
 
 
 
 
 
 
 
6.0

Net income
 
 
 
 
 
 
 
 
 
 
 
$
53.8

Total assets
 
$
4,012.8

 
$
1,997.8

 
$
990.3

 
$
242.7

 
$
(1,289.2
)
 
$
5,954.4

 
 
(1)
Other/Eliminations represents the elimination of intersegment transactions as well as unallocated corporate costs consisting of costs specifically related to parent company operations that do not directly benefit segments, either individually or collectively.


19


Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Our operations are structured into four operating segments that represent the geographic areas under which we operate and manage our business. These segments are Univar USA (“USA”), Univar Canada (“Canada”), Univar Europe and the Middle East and Africa (“EMEA”), and Rest of World (“Rest of World”), which includes developing businesses in Latin America (including Brazil and Mexico) and the Asia-Pacific region.
We monitor the results of our operating segments separately for the purposes of making decisions about resource allocation and performance assessment. We evaluate performance on the basis of Adjusted EBITDA, which we define as our consolidated net income, plus the sum of interest expense, net of interest income, income tax expense, depreciation, amortization, loss on extinguishment of debt, other operating expenses, net (which primarily consists of acquisition and integration related expenses, employee stock-based compensation expense, restructuring charges, business optimization, and other unusual or non-recurring expenses) and other (expense) income, net (which consists of gains and losses on foreign currency transactions and undesignated derivative instruments, debt refinancing costs, and other nonoperating activity). We believe that Adjusted EBITDA is an important indicator of operating performance because:
we report Adjusted EBITDA to our lenders as required under the covenants of our credit agreements;
Adjusted EBITDA excludes the effects of income taxes, as well as the effects of financing and investing activities by eliminating the effects of interest, depreciation and amortization expenses;
we use Adjusted EBITDA in setting performance incentive targets;
we consider gains (losses) on the acquisition, disposal and impairment of assets as resulting from investing decisions rather than ongoing operations; and
other significant items, while periodically affecting our results, may vary significantly from period to period and have a disproportionate effect in a given period, which affects comparability of our results.
We set transfer prices between operating segments on an arms-length basis in a similar manner to transactions with third parties. We allocate corporate operating expenses that directly benefit our operating segments on a basis that reasonably approximates our estimates of the use of these services.
Other/Eliminations represents the elimination of inter-segment transactions as well as unallocated corporate costs consisting of costs specifically related to parent company operations that do not directly benefit segments, either individually or collectively. In the analysis of our results of operations, we discuss operating segment results for the current reporting period following our consolidated results of operations period-to-period comparison.
The following is management’s discussion and analysis of the financial condition and results of operations for the three and six months ended June 30, 2017 as compared to the corresponding period in the prior year. This discussion should be read in conjunction with the condensed consolidated financial statements, including the related notes, set forth in this report under “Financial Statements” and our Annual Report on Form 10-K for the year ended December 31, 2016 .

Results of Operations
The following tables set forth, for the periods indicated, certain statements of operations data first on the basis of reported data and then as a percentage of total net sales for the relevant period.








20

Table of Contents

Three Months Ended June 30, 2017 Compared to Three Months Ended June 30, 2016
 
 
 
Three Months Ended
 
Favorable
(unfavorable)
 
% Change
 
Impact of
currency (1)
(in millions)
 
June 30, 2017
 
June 30, 2016
 
Net sales
 
$
2,247.0

 
100.0
 %
 
$
2,262.5

 
100.0
 %
 
$
(15.5
)
 
(0.7
)%
 
(1.4
)%
Cost of goods sold
 
1,780.6

 
79.2
 %
 
1,817.1

 
80.3
 %
 
36.5

 
(2.0
)%
 
1.5
 %
Gross profit
 
$
466.4

 
20.8
 %
 
$
445.4

 
19.7
 %
 
$
21.0

 
4.7
 %
 
(1.3
)%
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outbound freight and handling
 
71.9

 
3.2
 %
 
73.3

 
3.2
 %
 
1.4

 
(1.9
)%
 
1.0
 %
Warehousing, selling and administrative
 
233.6

 
10.4
 %
 
223.9

 
9.9
 %
 
(9.7
)
 
4.3
 %
 
0.9
 %
Other operating expenses, net
 
24.2

 
1.1
 %
 
11.5

 
0.5
 %
 
(12.7
)
 
110.4
 %
 
(1.7
)%
Depreciation
 
34.1

 
1.5
 %
 
38.0

 
1.7
 %
 
3.9

 
(10.3
)%
 
0.8
 %
Amortization
 
16.5

 
0.7
 %
 
23.3

 
1.0
 %
 
6.8

 
(29.2
)%
 
1.7
 %
Total operating expenses
 
$
380.3

 
16.9
 %
 
$
370.0

 
16.4
 %
 
$
(10.3
)
 
2.8
 %
 
0.9
 %
Operating income
 
$
86.1

 
3.8
 %
 
$
75.4

 
3.3
 %
 
$
10.7

 
14.2
 %
 
(3.4
)%
Other (expense) income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest income
 
0.8

 
 %
 
1.0

 
 %
 
(0.2
)
 
(20.0
)%
 
 %
Interest expense
 
(36.6
)
 
(1.6
)%
 
(41.4
)
 
(1.8
)%
 
4.8

 
(11.6
)%
 
0.2
 %
Other (expense) income, net
 
(11.7
)
 
(0.5
)%
 
5.7

 
0.3
 %
 
(17.4
)
 
N/M

 
12.3
 %
Total other expense
 
$
(47.5
)
 
(2.1
)%
 
$
(34.7
)
 
(1.5
)%
 
$
(12.8
)
 
36.9
 %
 
2.3
 %
Income before income taxes
 
38.6

 
1.7
 %
 
40.7

 
1.8
 %
 
(2.1
)
 
(5.2
)%
 
(4.4
)%
Income tax expense
 
7.3

 
0.3
 %
 
0.9

 
 %
 
(6.4
)
 
711.1
 %
 
(677.8
)%
Net income
 
$
31.3

 
1.4
 %
 
$
39.8

 
1.8
 %
 
$
(8.5
)
 
(21.4
)%
 
(19.8
)%
 
 
(1)
Foreign currency translation is included in the percentage change. Unfavorable impacts from foreign currency translation are designated with parentheses.
Net sales
Net sales percentage change due to:        
Reported sales volumes
(5.8
)%
Sales pricing and product mix
6.5
 %
Foreign currency translation
(1.4
)%
Total
(0.7
)%
Net sales were $2,247.0 million for the three months ended June 30, 2017 , a decrease of $15.5 million , or 0.7% , from the three months ended June 30, 2016 . The decrease in net sales from reported sales volumes was driven by the USA, EMEA, and Rest of World segments, partially offset by higher sales volumes in the Canada segment. The increase in net sales from changes in sales pricing and product mix was driven by the USA, EMEA, and Rest of World segments, partially offset by a decrease in the Canada segment. Foreign currency translation decreased net sales, due to the US dollar strengthening against the British pound, euro, Canadian dollar, and Mexican peso, partially offset by the weakening of the US dollar against the Brazilian real. Refer to the “Segment results” for the three months ended June 30, 2017 discussion for additional information.
Gross profit
Gross profit percentage change due to:        
Reported sales volumes
(5.8
)%
Sales pricing, product costs and other adjustments
11.8
 %
Foreign currency translation
(1.3
)%
Total
4.7
 %

21

Table of Contents

Gross profit increased $21.0 million , or 4.7% , to $466.4 million for the three months ended June 30, 2017 . The decrease in gross profit from reported sales volumes was driven by the USA, EMEA, and Rest of World segments, partially offset by higher sales volumes in the Canada segment. The increase in gross profit from changes in sales pricing, product costs and other adjustments was driven by all of our segments. Gross margin, which we define as gross profit divided by net sales, increased to 20.8% for the three months ended June 30, 2017 from 19.7% for the three months ended June 30, 2016 primarily due to favorable product mix and focused margin management efforts. Foreign currency translation decreased gross profit due to the strengthening of the US dollar against the British pound, euro, Canadian dollar, and Mexican peso, partially offset by the weakening of the US dollar against the Brazilian real. Refer to the “Segment results” for the three months ended June 30, 2017 discussion for additional information.
Outbound freight and handling
Outbound freight and handling expenses decreased $1.4 million , or 1.9% , to $71.9 million for the three months ended June 30, 2017 . Foreign currency translation decreased outbound freight and handling expense by 1.0% , or $0.7 million . On a constant currency basis, outbound freight and handling expenses decreased 0.9% , or $0.7 million primarily due to lower reported sales volumes offset by higher delivery costs resulting from changes in product mix, market capacity constraints, and higher fuel costs. Refer to the “Segment results” for the three months ended June 30, 2017 discussion for additional information.
Warehousing, selling and administrative
Warehousing, selling and administrative expenses increased $9.7 million , or 4.3% , to $233.6 million for the three months ended June 30, 2017 . Foreign currency translation decreased warehousing, selling and administrative expenses by 0.9% , or $2.0 million . On a constant currency basis, the $11.7 million increase is primarily due to higher personnel costs of $13.9 million primarily due to higher variable compensation expense and $3.6 million in higher outsourced services and consulting fees. The increases were partially offset by $0.9 million in lower legal fees and $0.8 million in lower insurance expense. The remaining $4.1 million decrease related to several insignificant components. Refer to the “Segment results” for the three months ended June 30, 2017 discussion for additional information.
Other operating expenses, net
Other operating expenses, net increased $12.7 million from $11.5 million for the three months ended June 30, 2016 to $24.2 million for the three months ended June 30, 2017 . The increase was primarily related to $11.5 million of costs incurred to support the transformation of the US business and $3.8 million of higher stock-based compensation. The increase was partially offset by $3.7 million in lower restructuring charges and $1.9 million in lower acquisition and integration related expenses. The remaining $3.0 million increase related to several insignificant components. Foreign currency translation increased other operating expenses, net by 1.7% , or $0.2 million . Refer to “ Note 4: Other operating expenses, net ” and “ Note 5: Restructuring charges ” in Item 1 of this Quarterly Report on Form 10-Q for additional information. 
Depreciation and amortization
Depreciation expense decreased $3.9 million , or 10.3% , to $34.1 million for the three months ended June 30, 2017 . Foreign currency translation decreased depreciation expense by 0.8% , or $0.3 million . On a constant currency basis, the $3.6 million decrease was primarily related to the second quarter 2016 reassessment of useful lives of certain internally developed software which were fully depreciated by May 2017. The decrease in depreciation expense also resulted from asset retirements.
Amortization expense decreased $6.8 million , or 29.2% , to $16.5 million for the three months ended June 30, 2017 . Foreign currency translation decreased amortization expense by 1.7% , or $ 0.4 million . On a constant currency basis, the decrease of $6.4 million was primarily driven by the third quarter 2016 impairment charge which reduced the intangible asset base along with lower expense related to intangibles reaching the end of their useful life.
Interest expense
Interest expense decreased $4.8 million , or 11.6% , to $36.6 million for the three months ended June 30, 2017 primarily due to lower average outstanding borrowings, as well as lower interest rates related to the January 2017 debt amendment of the Senior Term B loan agreement.
Other (expense) income, net
Other (expense) income, net changed by $17.4 million from an income of $5.7 million for the three months ended June 30, 2016 to an expense of $11.7 million for the three months ended June 30, 2017 . The change was primarily driven by foreign currency denominated loan revaluation losses of $5.4 million primarily resulting from the revaluation of the Euro Tranche Term Loan in the three months ended June 30, 2017 compared to the gains of $5.4 million in the three months ended June 30, 2016 . The change

22

Table of Contents

was also driven by the mark-to-market loss for interest rate swaps of $4.8 million in the three months ended June 30, 2017 compared to the gains of $1.5 million in the three months ended June 30, 2016 . The remaining $0.3 million change is related to several insignificant components. Refer to “ Note 6: Other expense, net ” in Item 1 of this Quarterly Report on Form 10-Q for additional information.
Income tax expense
Income tax expense increased $6.4 million from $0.9 million for the three months ended June 30, 2016 to $7.3 million for the three months ended June 30, 2017 with the impact of a slight decrease in earnings offset by an unfavorable discrete item expense. As compared to the $0.4 million of discrete benefit recorded for the three months of 2016, $0.1 million of discrete expense was recorded for the three month period ended June 30, 2017 .
In April 2017 President Trump signed an Executive Order directing the US Department of the Treasury (“Treasury”) to review tax regulations adopted over the past 18 months under former President Obama. In July 2017, Treasury issued Notice 2017-38 which initially identified certain tax regulations which met the criteria established by the Executive Order. The Company’s income tax expense was negatively impacted in December 2016 by a $47.3 million charge due to a tax regulation relating to the unrealized foreign exchange loss of non US branches which is currently under review by Treasury. Should the tax regulation be repealed, the Company would expect a favorable impact to its income tax expense during the quarter the law is enacted. Treasury expects to release its recommendation by September 2017.






















23

Table of Contents


Segment results
Our Adjusted EBITDA by operating segment and in aggregate is summarized in the following tables:
 
(in millions)
 
USA
 
Canada    
 
EMEA    
 
Rest of
World    
 
Other/
Eliminations (1)  
 
Consolidated    
 
 
Three months ended June 30, 2017
Net sales:
 
 
 
 
 
 
 
 
External customers
 
$
1,191.1

 
$
492.4

 
$
463.7

 
$
99.8

 
$

 
$
2,247.0

Inter-segment
 
35.0

 
2.3

 
1.2

 
0.2

 
(38.7
)
 

Total net sales
 
$
1,226.1

 
$
494.7

 
$
464.9

 
$
100.0

 
$
(38.7
)
 
$
2,247.0

Cost of goods sold
 
950.4

 
427.2

 
360.2

 
81.5

 
(38.7
)
 
1,780.6

Gross profit
 
$
275.7

 
$
67.5

 
$
104.7

 
$
18.5

 
$

 
$
466.4

Outbound freight and handling
 
47.3

 
9.2

 
13.8

 
1.6

 

 
71.9

Warehousing, selling and administrative
 
136.4

 
21.5

 
54.6

 
12.0

 
9.1

 
233.6

Adjusted EBITDA
 
$
92.0

 
$
36.8

 
$
36.3

 
$
4.9

 
$
(9.1
)
 
$
160.9

Other operating expenses, net
 
 
 
 
 
 
 
24.2

Depreciation
 
 
 
 
 
 
 
34.1

Amortization
 
 
 
 
 
 
 
16.5

Interest expense, net
 
 
 
 
 
 
 
35.8

Other expense, net
 
 
 
 
 
 
 
11.7

Income tax expense
 
 
 
 
 
 
 
7.3

Net income
 
 
 
 
 
 
 
$
31.3

(in millions)
 
USA
 
Canada
 
EMEA
 
Rest of
World
 
Other/
Eliminations (1)  
 
Consolidated    
 
 
Three months ended June 30, 2016
Net sales:
 
 
 
 
 
 
 
 
External customers
 
$
1,212.8

 
$
485.4

 
$
459.9

 
$
104.4

 
$

 
$
2,262.5

Inter-segment
 
25.0

 
1.7

 
1.0

 

 
(27.7
)
 

Total net sales
 
$
1,237.8

 
$
487.1

 
$
460.9

 
$
104.4

 
$
(27.7
)
 
$
2,262.5

Cost of goods sold
 
974.7

 
426.5

 
357.8

 
85.8

 
(27.7
)
 
1,817.1

Gross profit
 
$
263.1

 
$
60.6

 
$
103.1

 
$
18.6

 
$

 
$
445.4

Outbound freight and handling
 
48.2

 
8.4

 
14.8

 
1.9

 

 
73.3

Warehousing, selling and administrative
 
131.7

 
20.7

 
55.3

 
12.5

 
3.7

 
223.9

Adjusted EBITDA
 
$
83.2

 
$
31.5

 
$
33.0

 
$
4.2

 
$
(3.7
)
 
$
148.2

Other operating expenses, net
 
 
 
 
 
 
 
11.5

Depreciation
 
 
 
 
 
 
 
38.0

Amortization
 
 
 
 
 
 
 
23.3

Interest expense, net
 
 
 
 
 
 
 
40.4

Other income, net
 
 
 
 
 
 
 
(5.7
)
Income tax expense
 
 
 
 
 
 
 
0.9

Net income
 
 
 
 
 
 
 
$
39.8

 
 
(1)
Other/Eliminations represents the elimination of intersegment transactions as well as unallocated corporate costs consisting of costs specifically related to parent company operations that do not directly benefit segments, either individually or collectively.

24

Table of Contents


USA .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Reported sales volumes
 
(7.3
)%
 
Reported sales volumes
 
(7.3
)%
Sales pricing and product mix
 
5.5
 %
 
Sales pricing, product costs and other adjustments
 
12.1
 %
Total
 
(1.8
)%
 
Total
 
4.8
 %
External sales in the USA segment were $1,191.1 million , a decrease of $21.7 million , or 1.8% , for the three months ended June 30, 2017 due to lower sales volumes, partially offset by higher average selling prices resulting from the Company's efforts to improve its sales force effectiveness and margin management initiatives. Gross profit increased $12.6 million , or 4.8% , to $275.7 million for the three months ended June 30, 2017 . Gross profit increased due to sales pricing primarily due to higher average selling prices and increased sales of higher margin products. Gross margin increased from 21.7% for the three months ended June 30, 2016 to 23.1% during the three months ended June 30, 2017 primarily due to the factors impacting gross profit discussed above.
Outbound freight and handling expenses decreased $0.9 million , or 1.9% , to $47.3 million for the three months ended June 30, 2017 primarily due to lower reported sales volumes, partially offset by higher delivery costs resulting from a combination of market capacity constraints and higher fuel costs. Operating expenses increased $4.7 million , or 3.6% , to $136.4 million for the three months ended June 30, 2017 of which $8.8 million is attributable to higher personnel expenses primarily driven by higher variable compensation expense and $1.2 million of higher outsourced services and consulting fees, partially offset by $1.1 million in lower environmental remediation expense, $0.8 million in lower insurance expense, and $0.5 million of lower lease expenses. The remaining $2.9 million decrease related to several insignificant components. Operating expenses as a percentage of external sales increased from 10.9% for the three months ended June 30, 2016 to 11.5% for the three months ended June 30, 2017 .
Adjusted EBITDA increased by $8.8 million , or 10.6% , to $92.0 million for the three months ended June 30, 2017 . Adjusted EBITDA margin increased from 6.9% in the three months ended June 30, 2016 to 7.7% for the three months ended June 30, 2017 primarily as a result of higher gross margin, partially offset by increased operating expenses as a percentage of sales.
Canada .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Reported sales volumes
 
8.5
 %
 
Reported sales volumes
 
8.5
 %
Sales pricing and product mix
 
(4.4
)%
 
Sales pricing, product costs and other adjustments
 
6.9
 %
Foreign currency translation
 
(2.7
)%
 
Foreign currency translation
 
(4.0
)%
Total
 
1.4
 %
 
Total
 
11.4
 %
External sales in the Canada segment were $492.4 million , an increase of $7.0 million , or 1.4% , for the three months ended June 30, 2017 . Foreign currency translation decreased external sales dollars as the US dollar strengthened against the Canadian dollar when comparing the three months ended June 30, 2017 to the three months ended June 30, 2016 . On a constant currency basis, external sales dollars increased $20.2 million , or 4.1% . The increase in external net sales was driven by higher reported sales volumes across all regions. The decrease in external net sales from changes in sales pricing was primarily driven by a change in market and product mix as a result of a soft agricultural season. Gross profit increased $6.9 million , or 11.4% , to $67.5 million in the three months ended June 30, 2017 . Gross profit increased primarily due to sales pricing and product cost improvements in the energy and industrial end markets driven by product mix and margin management efforts and higher supplier rebates during the three months ended June 30, 2017 . Gross margin increased from 12.5% for the three months ended June 30, 2016 to 13.7% for the three months ended June 30, 2017 primarily due to the factors impacting gross profit discussed above.
Outbound freight and handling expenses increased $0.8 million , or 9.5% , to $9.2 million for the three months ended June 30, 2017 primarily due to higher reported sales volumes and higher delivery costs resulting from changes in end market and product mix. Operating expenses increased by $0.8 million , or 3.9% , to $21.5 million for the three months ended June 30, 2017 , and increased as a percentage of external sales from 4.3% for the three months ended June 30, 2016 to 4.4% for the three months ended June 30, 2017 . Foreign currency translation decreased operating expenses by 4.3% , or $0.9 million . On a constant currency basis, operating expenses increased $1.7 million , or 8.2% , primarily due to increased personnel expenses of $1.2 million driven by higher variable compensation expense. The remaining $0.5 million increase related to several insignificant components.

25

Table of Contents

Adjusted EBITDA increased by $5.3 million , or 16.8% , to $36.8 million for the three months ended June 30, 2017 . Foreign currency translation decreased Adjusted EBITDA by 3.5% , or $ 1.1 million . On a constant currency basis, Adjusted EBITDA increased $6.4 million , or 20.3% , primarily due to increased gross profit. Adjusted EBITDA margin increased from 6.5% for the three months ended June 30, 2016 to 7.5% for the three months ended June 30, 2017 primarily as a result of higher gross margin, partially offset by higher outbound freight and handling expenses as a percentage of sales.
EMEA .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Reported sales volumes
 
(6.6
)%
 
Reported sales volumes
 
(6.6
)%
Sales pricing and product mix
 
11.7
 %
 
Sales pricing, product costs and other adjustments
 
12.0
 %
Foreign currency translation
 
(4.3
)%
 
Foreign currency translation
 
(3.8
)%
Total
 
0.8
 %
 
Total
 
1.6
 %
External sales in the EMEA segment were $463.7 million , an increase of $3.8 million , or 0.8% , for the three months ended June 30, 2017 , primarily due to higher average selling prices driven by mix improvement, and margin management initiatives, partially offset by lower volumes primarily due to three less selling days for the three months ended June 30, 2017 compared to the three months ended June 30, 2016 . Foreign currency translation decreased external sales dollars resulting from the US dollar strengthening against the British pound and the euro, when comparing the three months ended June 30, 2017 to the three months ended June 30, 2016 . Gross profit increased $1.6 million , or 1.6% , to $104.7 million in the three months ended June 30, 2017 . Gross profit increased due to changes in sales pricing, product costs and other adjustments primarily due to increased sales of higher margin pharmaceutical finished goods as well as the continued impact of favorable product and end market mix. Gross margin increased from 22.4% for the three months ended June 30, 2016 to 22.6% for the three months ended June 30, 2017 primarily due to the factors discussed above.
Outbound freight and handling expenses decreased $1.0 million , or 6.8% , to $13.8 million , primarily due to lower reported sales volumes. Operating expenses decreased $0.7 million , or 1.3% , to $54.6 million for the three months ended June 30, 2017 , and decreased as a percentage of external sales from 12.0% for the three months ended June 30, 2016 to 11.8% for the three months ended June 30, 2017 . Foreign currency translation decreased operating expenses by 2.2% , or $1.2 million . On a constant currency basis, operating expenses increased $0.5 million , or 0.9% , which was primarily due to higher environmental remediation expense of $0.8 million. The remaining $0.3 million offsetting decrease related to several other insignificant components.
Adjusted EBITDA increased by $3.3 million , or 10.0% , to $36.3 million for the three months ended June 30, 2017 . Foreign currency translation decreased Adjusted EBITDA by 7.0% , or $ 2.3 million . On a constant currency basis, Adjusted EBITDA increased $ 5.6 million , or 17.0% . Adjusted EBITDA growth in the quarter can be attributed to increased sales of pharmaceutical finished goods, along with improved sales force execution and margin management initiatives and continued reductions in outbound freight and handling expenses. For the three months ended June 30, 2017 , the pharmaceutical finished goods product line represented approximately 30% of Adjusted EBIDTA in the EMEA segment. Adjusted EBITDA margin increased from 7.2% for the three months ended June 30, 2016 to 7.8% for the three months ended June 30, 2017 primarily due to higher gross margin and lower outbound freight and handling expenses and operating expenses as a percentage of sales.
Rest of World .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Reported sales volumes
 
(16.0
)%
 
Reported sales volumes
 
(16.0
)%
Sales pricing and product mix
 
11.0
 %
 
Sales pricing, product costs and other adjustments
 
12.8
 %
Foreign currency translation
 
0.6
 %
 
Foreign currency translation
 
2.7
 %
Total
 
(4.4
)%
 
Total
 
(0.5
)%
External sales in the Rest of World segment were $99.8 million , a decrease of $4.6 million , or 4.4% , for the three months ended June 30, 2017 . Foreign currency translation increased external sales dollars when comparing the three months ended June 30, 2017 to the three months ended June 30, 2016 primarily due to the US dollar weakening against the Brazilian real, partially offset by the US dollar strengthening against the Mexican peso. The decrease in external net sales from reported sales volumes was due to weak industrial demand and in particular lower demand in upstream oil and gas products and solvents in Mexico . The increase in external net sales from changes in sales pricing and product mix was primarily due to favorable product mix and higher average selling prices resulting from the Company's efforts to improve its sales force effectiveness . Gross profit decreased $0.1 million ,

26

Table of Contents

or 0.5% , to $18.5 million for the three months ended June 30, 2017 as margin management efforts largely offset lower volumes across the region. Gross margin increased from 17.8% for the three months ended June 30, 2016 to 18.5% for the three months ended June 30, 2017 primarily due to the factors discussed above.
Outbound freight and handling expenses decreased $0.3 million , or 15.8% , to $1.6 million for the three months ended June 30, 2017 , primarily due to delivery cost efficiencies resulting from changes in product mix and lower volumes. Operating expenses decreased $0.5 million , or 4.0% , to $12.0 million for the three months ended June 30, 2017 and were flat as a percentage of external sales at 12.0% when comparing the three months ended June 30, 2016 to the three months ended June 30, 2017 . Foreign currency translation increased operating expenses by 2.4% , or $0.3 million . On a constant currency basis, operating expenses decreased $0.8 million , or 6.4% , due to several insignificant components.
Adjusted EBITDA increased by $0.7 million , or 16.7% , to $4.9 million for the three months ended June 30, 2017 . Foreign currency translation increased Adjusted EBITDA by 4.8% , or $0.2 million . On a constant currency basis, Adjusted EBITDA increased $0.5 million , or 11.9% , primarily due to the benefit from reductions in outbound freight and handling expenses and operating expenses, partially offset by gross profit reductions. Adjusted EBITDA margin increased from 4.0% for the three months ended June 30, 2016 to 4.9% for the three months ended June 30, 2017 primarily due to lower outbound freight and handling expenses as a percentage of sales.
Six Months Ended June 30, 2017 Compared to Six Months Ended June 30, 2016
 
 
Six Months Ended
 
Favorable
(unfavorable)
 
% Change
 
Impact of
currency (1)
(in millions)
 
June 30, 2017
 
June 30, 2016
 
Net sales
 
$
4,245.8

 
100.0
 %
 
$
4,261.5

 
100.0
 %
 
$
(15.7
)
 
(0.4
)%
 
(1.1
)%
Cost of goods sold
 
3,340.0

 
78.7
 %
 
3,385.8

 
79.5
 %
 
45.8

 
(1.4
)%
 
1.2
 %
Gross profit
 
$
905.8

 
21.3
 %
 
$
875.7

 
20.5
 %
 
$
30.1

 
3.4
 %
 
(1.0
)%
Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Outbound freight and handling
 
142.9

 
3.4
 %
 
144.6

 
3.4
 %
 
1.7

 
(1.2
)%
 
0.7
 %
Warehousing, selling and administrative
 
459.7

 
10.8
 %
 
448.8

 
10.5
 %
 
(10.9
)
 
2.4
 %
 
2.1
 %
Other operating expenses, net
 
44.0

 
1.0
 %
 
17.0

 
0.4
 %
 
(27.0
)
 
158.8
 %
 
(1.8
)%
Depreciation
 
70.0

 
1.6
 %
 
71.5

 
1.7
 %
 
1.5

 
(2.1
)%
 
0.6
 %
Amortization
 
33.2

 
0.8
 %
 
45.3

 
1.1
 %
 
12.1

 
(26.7
)%
 
0.9
 %
Total operating expenses
 
$
749.8

 
17.7
 %
 
$
727.2

 
17.1
 %
 
$
(22.6
)
 
3.1
 %
 
0.6
 %
Operating income
 
$
156.0

 
3.7
 %
 
$
148.5

 
3.5
 %
 
$
7.5

 
5.1
 %
 
(3.0
)%
Other (expense) income:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest income
 
1.7

 
 %
 
1.9

 
 %
 
(0.2
)
 
(10.5
)%
 
 %
Interest expense
 
(73.3
)
 
(1.7
)%
 
(82.9
)
 
(1.9
)%
 
9.6

 
(11.6
)%
 
0.4
 %
Loss on extinguishment of debt
 
(0.8
)
 
 %
 

 
 %
 
(0.8
)
 
100.0
 %
 
 %
Other expense, net
 
(20.8
)
 
(0.5
)%
 
(7.7
)
 
(0.2
)%
 
(13.1
)
 
170.1
 %
 
23.4
 %
Total other expense
 
$
(93.2
)
 
(2.2
)%
 
$
(88.7
)
 
(2.1
)%
 
$
(4.5
)
 
5.1
 %
 
2.4
 %
Income before income taxes
 
62.8

 
1.5
 %
 
59.8

 
1.4
 %
 
3.0

 
5.0
 %
 
(4.0
)%
Income tax expense
 
8.9

 
0.2
 %
 
6.0

 
0.1
 %
 
(2.9
)
 
48.3
 %
 
(113.3
)%
Net income
 
$
53.9

 
1.3
 %
 
$
53.8

 
1.3
 %
 
$
0.1

 
0.2
 %
 
(17.1
)%
 
 
(1)
Foreign currency translation is included in the percentage change. Unfavorable impacts from foreign currency translation are designated with parentheses.
Net sales
Net sales percentage change due to:        
Acquisitions
0.1
 %
Reported sales volumes
(4.6
)%
Sales pricing and product mix
5.2
 %
Foreign currency translation
(1.1
)%
Total
(0.4
)%

27

Table of Contents

Net sales were $4,245.8 million for the six months ended June 30, 2017 , a decrease of $15.7 million , or 0.4% , from the six months ended June 30, 2016 . The increase in net sales from acquisitions was driven by the March 2016 Nexus Ag acquisition in Canada and the March 2016 Bodine acquisition in the USA. The decrease in net sales from reported sales volumes was driven by the USA, EMEA, and Rest of World segments, partially offset by higher sales volumes in the Canada segment. The increase in net sales from changes in sales pricing and product mix was driven by the USA, EMEA, and Rest of World segments, partially offset by a decrease in the Canada segment. Foreign currency translation decreased net sales, due to the US dollar strengthening against the British pound, euro, Canadian dollar, and Mexican peso, partially offset by the weakening of the US dollar against the Brazilian real. Refer to the “Segment results” for the six months ended June 30, 2017 discussion for additional information.
Gross profit
Gross profit percentage change due to:        
Acquisitions
0.2
 %
Reported sales volumes
(4.6
)%
Sales pricing, product costs and other adjustments
8.8
 %
Foreign currency translation
(1.0
)%
Total
3.4
 %
Gross profit increased $30.1 million , or 3.4% , to $905.8 million for the six months ended June 30, 2017 . The increase in gross profit from acquisitions was driven by the March 2016 Bodine acquisition in the USA and March 2016 Nexus Ag acquisition in Canada. The decrease in gross profit from reported sales volumes was driven by the USA, EMEA, and Rest of World segments, partially offset by higher sales volumes in the Canada segment. The increase in gross profit from changes in sales pricing, product costs and other adjustments was driven by all of our segments. Gross margin, which we define as gross profit divided by net sales, increased to 21.3% for the six months ended June 30, 2017 from 20.5% for the six months ended June 30, 2016 primarily due to favorable product mix and focused margin management efforts. Foreign currency translation decreased gross profit due to the strengthening of the US dollar against the British pound, euro, Canadian dollar, and Mexican peso, partially offset by the weakening of the US dollar against the Brazilian real. Refer to the “Segment results” for the six months ended June 30, 2017 discussion for additional information.
Outbound freight and handling
Outbound freight and handling expenses decreased $1.7 million , or 1.2% , to $142.9 million for the six months ended June 30, 2017 . Foreign currency translation decreased outbound freight and handling expense by 0.7% , or $1.0 million . On a constant currency basis, outbound freight and handling expenses decreased 0.5% , or $0.7 million primarily due to lower reported sales volumes offset by higher delivery costs resulting from changes in product mix, market capacity constraints, and increasing fuel prices. Refer to the “Segment results” for the six months ended June 30, 2017 discussion for additional information.
Warehousing, selling and administrative
Warehousing, selling and administrative expenses increased $10.9 million , or 2.4% , to $459.7 million for the six months ended June 30, 2017 . Foreign currency translation decreased warehousing, selling and administrative expenses by 2.1% , or $3.2 million . On a constant currency basis, the $ 14.1 million increase is primarily due to higher personnel costs of $22.1 million primarily driven by higher variable compensation expense, including the absence of $4.5 million in prior service credits recognized in 2016 related to the US retiree health care plan, partially offset by $2.3 million in lower lease expense, driven by site closures, and $0.9 million in lower insurance expense. The remaining $4.8 million decrease related to several insignificant components. Refer to the “Segment results” for the six months ended June 30, 2017 discussion for additional information.
Other operating expenses, net
Other operating expenses, net increased $ 27.0 million from $ 17.0 million for the six months ended June 30, 2016 to $ 44.0 million for the six months ended June 30, 2017 . The increase was primarily related to $20.6 million of costs incurred to support the transformation of the US business, $8.0 million of higher stock-based compensation, and $3.2 million of higher non-program specific severance costs. The increase was partially offset by $3.6 million in lower acquisition and integration related expenses and $3.0 million in lower restructuring charges. The remaining $1.8 million increase related to several insignificant components. Foreign currency translation increased other operating expenses, net by 1.8% , or $0.3 million . Refer to “ Note 4: Other operating expenses, net ” and “ Note 5: Restructuring charges ” in Item 1 of this Quarterly Report on Form 10-Q for additional information. 



28

Table of Contents

Depreciation and amortization
Depreciation expense decreased $ 1.5 million , or 2.1% , to $ 70.0 million for the six months ended June 30, 2017 . Foreign currency translation decreased depreciation expense by 0.6% , or $ 0.4 million . On a constant currency basis, the $ 1.1 million decrease was primarily due to asset retirements, partially offset by the increase in depreciation expense due to the second quarter 2016 reassessment of useful lives of certain internally developed software.
Amortization expense decreased $ 12.1 million , or 26.7% , to $ 33.2 million for the six months ended June 30, 2017 . Foreign currency translation decreased amortization expense by 0.9% , or $ 0.4 million . On a constant currency basis, the decrease of $ 11.7 million was primarily driven by the third quarter 2016 impairment charge which reduced the intangible asset base along with lower expense related to intangibles reaching the end of their useful life.
Interest expense
Interest expense decreased $ 9.6 million , or 11.6% , to $ 73.3 million for the six months ended June 30, 2017 primarily due to lower average outstanding borrowings, as well as lower interest rates related to the January 2017 debt amendment of the Senior Term B loan agreement.
Loss on extinguishment of debt
Loss on extinguishment of debt included $ 0.8 million for the six months ended June 30, 2017 due to the write off of unamortized debt discount and debt issuance costs related to the January 2017 debt amendment of the Senior Term B loan agreement.
Other expense, net
Other expense, net increased $13.1 million from $7.7 million for the six months ended June 30, 2016 to $20.8 million for the six months ended June 30, 2017 . The increase was primarily due to the $7.0 million increase from the mark-to-market loss for interest rate swaps of $4.8 million in the three months ended June 30, 2017 compared to the gains of $2.2 million in the three months ended June 30, 2016 . The increase was also driven by the $4.2 million in fees related to the January 2017 debt amendment of the Senior Term B loan agreement. The remaining $1.9 million increase is related to several insignificant components. Refer to “ Note 6: Other expense, net ” in Item 1 of this Quarterly Report on Form 10-Q for additional information.
Income tax expense
Income tax expense increased $ 2.9 million from $ 6.0 million for the six months ended June 30, 2016 to $ 8.9 million for the six months ended June 30, 2017 with the impact of an increase in earnings offset by a favorable discrete item benefit. As compared to the $0.9 million of discrete benefit for the six months of 2016, $3.8 million of discrete benefit was recorded for the six month period ended June 30, 2017 of which a $3.5 million benefit is related to excess tax benefits from share-based compensation.
In April 2017 President Trump signed an Executive Order directing the US Department of the Treasury (“Treasury”) to review tax regulations adopted over the past 18 months under former President Obama. In July 2017, Treasury issued Notice 2017-38 which initially identified certain tax regulations which met the criteria established by the Executive Order. The Company’s income tax expense was negatively impacted in December 2016 by a $47.3 million charge due to a tax regulation relating to the unrealized foreign exchange loss of non US branches which is currently under review by Treasury. Should the tax regulation be repealed, the Company would expect a favorable impact to its income tax expense during the quarter the law is enacted. Treasury expects to release its recommendation by September 2017.









29

Table of Contents

Segment results
Our Adjusted EBITDA by operating segment and in aggregate is summarized in the following tables:
(in millions)
 
USA
 
Canada    
 
EMEA    
 
Rest of
World    
 
Other/
Eliminations (1)    
 
Consolidated    
 
 
Six months ended June 30, 2017
Net sales:
 
 
 
 
 
 
 
 
External customers
 
$
2,342.0

 
$
799.7

 
$
903.4

 
$
200.7

 
$

 
$
4,245.8

Inter-segment
 
66.2

 
4.1

 
2.5

 
0.3

 
(73.1
)
 

Total net sales
 
$
2,408.2

 
$
803.8

 
$
905.9

 
$
201.0

 
$
(73.1
)
 
$
4,245.8

Cost of goods sold
 
1,869.6

 
680.5

 
699.4

 
163.6

 
(73.1
)
 
3,340.0

Gross profit
 
$
538.6

 
$
123.3

 
$
206.5

 
$
37.4

 
$

 
$
905.8

Outbound freight and handling
 
94.1

 
18.4

 
27.2

 
3.2

 

 
142.9

Warehousing, selling and administrative
 
270.8

 
43.3

 
107.1

 
22.6

 
15.9

 
459.7

Adjusted EBITDA
 
$
173.7

 
$
61.6

 
$
72.2

 
$
11.6

 
$
(15.9
)
 
$
303.2

Other operating expenses, net
 
 
 
 
 
 
 
44.0

Depreciation
 
 
 
 
 
 
 
70.0

Amortization
 
 
 
 
 
 
 
33.2

Interest expense, net
 
 
 
 
 
 
 
71.6

Loss on extinguishment of debt
 
 
 
 
 
 
 
0.8

Other expense, net
 
 
 
 
 
 
 
20.8

Income tax expense
 
 
 
 
 
 
 
8.9

Net income
 
 
 
 
 
 
 
$
53.9

(in millions)
 
USA
 
Canada
 
EMEA
 
Rest of
World
 
Other/
Eliminations (1)  
 
Consolidated    
 
 
Six Months Ended June 30, 2016
Net sales:
 
 
 
 
 
 
 
 
External customers
 
$
2,400.3

 
$
758.1

 
$
897.3

 
$
205.8

 
$

 
$
4,261.5

Inter-segment
 
51.9

 
4.0

 
2.4

 

 
(58.3
)
 

Total net sales
 
$
2,452.2

 
$
762.1

 
$
899.7

 
$
205.8

 
$
(58.3
)
 
$
4,261.5

Cost of goods sold
 
1,926.2

 
650.9

 
700.4

 
166.6

 
(58.3
)
 
3,385.8

Gross profit
 
$
526.0

 
$
111.2

 
$
199.3

 
$
39.2

 
$

 
$
875.7

Outbound freight and handling
 
95.9

 
16.2

 
28.8

 
3.7

 

 
144.6

Warehousing, selling and administrative
 
266.1

 
41.8

 
109.2

 
23.4

 
8.3

 
448.8

Adjusted EBITDA
 
$
164.0

 
$
53.2

 
$
61.3

 
$
12.1

 
$
(8.3
)
 
$
282.3

Other operating expenses, net
 
 
 
 
 
 
 
17.0

Depreciation
 
 
 
 
 
 
 
71.5

Amortization
 
 
 
 
 
 
 
45.3

Interest expense, net
 
 
 
 
 
 
 
81.0

Other expense, net
 
 
 
 
 
 
 
7.7

Income tax expense
 
 
 
 
 
 
 
6.0

Net income
 
 
 
 
 
 
 
$
53.8

 
 
(1)
Other/Eliminations represents the elimination of intersegment transactions as well as unallocated corporate costs consisting of costs specifically related to parent company operations that do not directly benefit segments, either individually or collectively.


30

Table of Contents

USA .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Acquisitions
 
0.1
 %
 
Acquisitions
 
0.2
 %
Reported sales volumes
 
(6.5
)%
 
Reported sales volumes
 
(6.5
)%
Sales pricing and product mix
 
4.0
 %
 
Sales pricing, product costs and other adjustments
 
8.7
 %
Total
 
(2.4
)%
 
Total
 
2.4
 %
External sales in the USA segment were $ 2,342.0 million , a decrease of $ 58.3 million , or 2.4% , for the six months ended June 30, 2017 due to lower sales volumes, partially offset by higher average selling prices resulting from the Company's efforts to improve its sales force effectiveness and margin management initiatives. The increase in external net sales from acquisitions was due to the March 2016 Bodine acquisition. Gross profit increased $12.6 million , or 2.4% , to $ 538.6 million for the six months ended June 30, 2017 . Gross profit increased due to sales pricing, product costs and other adjustments primarily due to higher average selling prices and increased sales of higher margin products. The increase in gross profit from acquisitions was due to the March 2016 Bodine acquisition. Gross margin increased from 21.9% for the six months ended June 30, 2016 to 23.0% during the six months ended June 30, 2017 primarily due to the factors impacting gross profit discussed above.
Outbound freight and handling expenses decreased $ 1.8 million , or 1.9% , to $ 94.1 million for the six months ended June 30, 2017 primarily due to lower reported sales volumes, partially offset by higher delivery costs resulting from market capacity constraints and increasing fuel prices. Operating expenses increased $4.7 million , or 1.8% , to $ 270.8 million for the six months ended June 30, 2017 of which $13.9 million is attributable to higher personnel costs primarily driven by higher variable compensation expense, including the absence of $4.5 million in prior service credits recognized in 2016 related to the US retiree health care plan, partially offset by $2.5 million of lower lease expenses, driven by site closures, $1.6 million in lower bad debt charges, and $1.0 million in lower insurance expense. The remaining $4.1 million decrease related to several insignificant components. Operating expenses as a percentage of external sales increased from 11.1% for the six months ended June 30, 2016 to 11.6% for the six months ended June 30, 2017 .
Adjusted EBITDA increased by $ 9.7 million , or 5.9% , to $ 173.7 million for the six months ended June 30, 2017 . Adjusted EBITDA margin increased from 6.8% in the six months ended June 30, 2016 to 7.4% for the six months ended June 30, 2017 primarily as a result of higher gross margin, partially offset by increased operating expenses as a percentage of sales.
Canada .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Acquisitions
 
0.5
 %
 
Acquisitions
 
0.6
 %
Reported sales volumes
 
8.2
 %
 
Reported sales volumes
 
8.2
 %
Sales pricing and product mix
 
(2.9
)%
 
Sales pricing, product costs and other adjustments
 
2.5
 %
Foreign currency translation
 
(0.3
)%
 
Foreign currency translation
 
(0.4
)%
Total
 
5.5
 %
 
Total
 
10.9
 %
External sales in the Canada segment were $ 799.7 million , an increase of $ 41.6 million , or 5.5% , for the six months ended June 30, 2017 . Foreign currency translation decreased external sales dollars as the US dollar strengthened against the Canadian dollar when comparing the six months ended June 30, 2017 to the six months ended June 30, 2016 . On a constant currency basis, external sales dollars increased $ 44.0 million , or 5.8% . The increase in external net sales from acquisitions was due to the March 2016 Nexus Ag acquisition. The increase in external net sales was driven by higher reported sales volumes across all regions. The decrease in external net sales from changes in sales pricing and product mix was primarily driven by a change in market and product mix, offsetting strong pricing gains achieved in Western Canada. Gross profit increased $ 12.1 million , or 10.9% , to $ 123.3 million in the six months ended June 30, 2017 . The increase in gross profit from acquisitions was due to the March 2016 Nexus Ag acquisition. Gross profit increased from sales pricing, product costs, and other adjustments due to margin management efforts and higher supplier rebates during the six months ended June 30, 2017 . Gross margin increased from 14.7% for the six months ended June 30, 2016 to 15.4% for the six months ended June 30, 2017 primarily due to the factors impacting gross profit discussed above.
Outbound freight and handling expenses increased $ 2.2 million , or 13.6% , to $ 18.4 million for the six months ended June 30, 2017 primarily due to higher reported sales volumes and higher delivery costs resulting from changes in product mix. Operating expenses increased by $ 1.5 million , or 3.6% , to $ 43.3 million for the six months ended June 30, 2017 , but decreased as a percentage

31

Table of Contents

of external sales from 5.5% for the six months ended June 30, 2016 to 5.4% for the six months ended June 30, 2017 . Foreign currency translation decreased operating expenses by 0.2% , or $ 0.1 million . On a constant currency basis, operating expenses increased $ 1.6 million , or 3.8% , primarily due to increased personnel expenses of $1.3 million driven by higher variable compensation expense and by merit compensation increases. The remaining $0.3 million increase related to several insignificant components.
Adjusted EBITDA increased by $ 8.4 million , or 15.8% , to $ 61.6 million for the six months ended June 30, 2017 . Foreign currency translation decreased Adjusted EBITDA by 0.4% , or $ 0.2 million. On a constant currency basis, Adjusted EBITDA increased $ 8.6 million, or 16.2% , primarily due to increased gross profit. Adjusted EBITDA margin increased from 7.0% for the six months ended June 30, 2016 to 7.7% for the six months ended June 30, 2017 primarily as a result of higher gross margin, partially offset by higher outbound freight and handling expenses as a percentage of sales.
EMEA .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Reported sales volumes
 
(4.3
)%
 
Reported sales volumes
 
(4.3
)%
Sales pricing and product mix
 
10.0
 %
 
Sales pricing, product costs and other adjustments
 
12.6
 %
Foreign currency translation
 
(5.0
)%
 
Foreign currency translation
 
(4.7
)%
Total
 
0.7
 %
 
Total
 
3.6
 %
External sales in the EMEA segment were $ 903.4 million , an increase of $ 6.1 million , or 0.7% , for the six months ended June 30, 2017 , primarily due to higher average selling prices driven by mix improvement, margin management initiatives, partially offset by lower volumes. Foreign currency translation decreased external sales dollars as the US dollar strengthened against the British pound and euro, when comparing the six months ended June 30, 2017 to the six months ended June 30, 2016 . Gross profit increased $ 7.2 million , or 3.6% , to $ 206.5 million in the six months ended June 30, 2017 . Gross profit increased due to changes in sales pricing, product costs and other adjustments primarily due to increased sales of higher margin pharmaceutical finished goods as well as the continued impact of favorable product and end market mix. Gross margin increased from 22.2% for the six months ended June 30, 2016 to 22.9% for the six months ended June 30, 2017 primarily due to the factors discussed above.
Outbound freight and handling expenses decreased $ 1.6 million , or 5.6% , to $ 27.2 million , primarily due to lower reported sales volumes. Operating expenses decreased $ 2.1 million , or 1.9% , to $ 107.1 million for the six months ended June 30, 2017 , and decreased as a percentage of external sales from 12.2% for the six months ended June 30, 2016 to 11.9% for the six months ended June 30, 2017 . Foreign currency translation decreased operating expenses by 3.0% , or $ 3.3 million . On a constant currency basis, operating expenses increased $ 1.2 million , or 1.1% , which was primarily due to higher environmental remediation expense of $0.7 million and $0.7 million in higher bad debt charges. The remaining offsetting $0.2 million decrease related to several other insignificant components.
Adjusted EBITDA increased by $ 10.9 million , or 17.8% , to $ 72.2 million for the six months ended June 30, 2017 . Foreign currency translation decreased Adjusted EBITDA by 8.5% , or $ 5.2 million. On a constant currency basis, Adjusted EBITDA increased $ 16.1 million, or 26.3% . Adjusted EBITDA growth in the first half can be attributed to increased sales of pharmaceutical finished goods compared to the first half of prior year and continued benefit from reductions in outbound freight and handling expenses. For the six months ended June 30, 2017 , the pharmaceutical finished goods product line represented approximately 30% of Adjusted EBIDTA in the EMEA segment. Adjusted EBITDA margin increased from 6.8% for the six months ended June 30, 2016 to 8.0% for the six months ended June 30, 2017 primarily due to higher gross margin and lower outbound freight and handling expenses and operating expenses as a percentage of sales.
Rest of World .
Net sales percentage change due to:
 
Gross profit percentage change due to:
Reported sales volumes
 
(10.7
)%
 
Reported sales volumes
 
(10.7
)%
Sales pricing and product mix
 
8.9
 %
 
Sales pricing, product costs and other adjustments
 
4.3
 %
Foreign currency translation
 
(0.7
)%
 
Foreign currency translation
 
1.8
 %
Total
 
(2.5
)%
 
Total
 
(4.6
)%
External sales in the Rest of World segment were $ 200.7 million , a decrease of $ 5.1 million , or 2.5% , for the six months ended June 30, 2017 . Foreign currency translation decreased external sales dollars when comparing the six months ended June 30, 2017 to the six months ended June 30, 2016 primarily due to the stronger US dollar position as compared to the Mexican peso,

32

Table of Contents

partially offset by the US dollar weakening against the Brazilian real. The decrease in external net sales from reported sales volumes was due to weak industrial demand and in particular lower demand in upstream oil and gas products and solvents in Mexico . The increase in external net sales from changes in sales pricing and product mix was primarily due to favorable product mix and higher average selling prices resulting from the Company's efforts to improve its sales force effectiveness . Gross profit decreased $ 1.8 million , or 4.6% , to $ 37.4 million for the six months ended June 30, 2017 . Gross profit increased from sales pricing, product costs and other adjustments primarily due to changes in selling prices offset with unfavorable product costs across the region for the six months ended June 30, 2017 . Gross margin decreased from 19.0% for the six months ended June 30, 2016 to 18.6% for the six months ended June 30, 2017 primarily due to the factors discussed above.
Outbound freight and handling expenses decreased $ 0.5 million , or 13.5% , to $ 3.2 million for the six months ended June 30, 2017 , primarily due to delivery cost efficiencies resulting from changes in product mix and lower volumes. Operating expenses decreased $ 0.8 million , or 3.4% , to $ 22.6 million for the six months ended June 30, 2017 and decreased as a percentage of external sales from 11.4% for the six months ended June 30, 2016 to 11.3% for the six months ended June 30, 2017 . Foreign currency translation increased operating expenses by 1.7% , or $ 0.4 million . On constant currency basis, operating expenses decreased $ 1.2 million , or 5.1% , which was primarily related to lower personnel expenses of $0.6 million due to reduced headcount. The remaining $0.6 million decrease related to several insignificant components.
Adjusted EBITDA decreased by $ 0.5 million , or 4.1% , to $ 11.6 million for the six months ended June 30, 2017 . Foreign currency translation increased Adjusted EBITDA by 2.5% , or $ 0.3 million . On a constant currency basis, Adjusted EBITDA decreased $ 0.8 million , or 6.6% , primarily due to gross profit reductions. Adjusted EBITDA margin decreased from 5.9% for the six months ended June 30, 2016 to 5.8% for the six months ended June 30, 2017 primarily due to lower gross margin, partially offset by lower operating expenses as a percentage of sales.
Liquidity and Capital Resources
Our primary source of liquidity is cash generated from our operations as well as borrowings under our credit facilities. As of June 30, 2017 , we had $712.8 million available under our credit facilities.
We are in compliance with our covenants. Our primary liquidity and capital resource needs are to service our debt and to finance working capital, capital expenditures, other liabilities and cost of acquisitions. We believe that funds provided by these sources will be adequate to meet the liquidity and capital resource needs for at least the next 12 months under current operating conditions. We will continue to balance our focus on sales and earnings growth with continuing efforts in cost control and working capital management.
Cash Flows
The following table presents a summary of our cash flow activity for the periods set forth below:
 
 
Six months ended
(in millions)
 
June 30, 2017
 
June 30, 2016
Net cash (used) provided by operating activities
 
$
(15.7
)
 
$
115.1

Net cash used by investing activities
 
(38.1
)
 
(98.8
)
Net cash provided (used) by financing activities
 
20.8

 
(1.2
)
Effect of exchange rate changes on cash and cash equivalents
 
18.4

 
20.6

Net (decrease) increase in cash and cash equivalents
 
$
(14.6
)
 
$
35.7

Cash (Used) Provided by Operating Activities
Cash (used) provided by operating activities decreased $130.8 million from cash provided of $115.1 million for the six months ended June 30, 2016 to cash used of $15.7 million for the six months ended June 30, 2017 .
Cash provided by operating activities decreased $1.0 million due to a decrease in net income exclusive of non-cash items. Net income exclusive of non-cash items was $168.6 million and 169.6 million in the six months ended June 30, 2017 and June 30, 2016 , respectively. Refer to “Results of Operations” above for additional information.
The change in trade working capital; which includes trade accounts receivable, net, inventories and trade accounts payable; resulted in an increased use of cash of $94.1 million . Inventories used cash of $37.9 million and provided cash of $18.3 million for the six months ended June 30, 2017 and June 30, 2016 , respectively. The current year cash outflows are primarily related to higher Ag inventory levels as a result of a soft agricultural season. Trade accounts receivable, net used cash of $321.6 million and

33

Table of Contents

$274.1 million for the six months ended June 30, 2017 and June 30, 2016 , respectively. The increase in current year cash outflows is primarily due to timing of customer payments compared to the prior six months ended June 30, 2016. Trade accounts payable provided cash inflows of $252.4 million and $242.8 million for the six months ended June 30, 2017 and June 30, 2016 , respectively. The cash inflows related to trade accounts payable are primarily due to improvements in managing inventory spending.
Prepaid expenses and other current assets also contributed $40.9 million to the increased use of cash. During the six months ended June 30, 2017 , prepaid expenses and other current assets used $13.2 million of cash, primarily due to increases in prepaid expenses, other receivables, and several other insignificant components. Prepaid expenses and other current assets provided cash of $27.7 million during the six months ended June 30, 2016 , which was primarily due to the receipt of cash related to rebates, income tax receivables, and several other insignificant components.
The change in pensions and other postretirement benefit liabilities provided cash of $1.0 million , which consisted of cash outflows of $19.2 million and $20.2 million for the six months ended June 30, 2017 and June 30, 2016 , respectively.
The remaining cash inflow related to operating activities of $4.2 million is related to other, net. During the six months ended June 30, 2017 and June 30, 2016 , other, net used $44.8 million and $49.0 million of cash, respectively, primarily due to the settlement of customer prepayment obligations.
Cash Used by Investing Activities
Cash used by investing activities decreased $60.7 million from $98.8 million for the six months ended June 30, 2016 to $38.1 million for the six months ended June 30, 2017 . The decrease is primarily related to lower cash outflows for purchases of businesses, net of cash acquired of $54.3 million primarily driven by the March 2016 acquisitions of Bodine and Nexus AG. Another factor contributing to the decrease in cash used by investing activities is a reduction in spending on capital expenditures of $6.6 million .
The remaining increase in cash used by investing activities of $0.2 million did not contain any significant activity.
Cash Provided (Used) by Financing Activities
Cash provided by financing activities increased $ 22.0 million from cash used of $ 1.2 million for the six months ended June 30, 2016 to cash provided of $ 20.8 million for the six months ended June 30, 2017 .
An increase in cash provided by financing activities of $13.1 million was primarily due to a net change in the ABL facilities of $53.9 million and $3.7 million for the six months ended June 30, 2017 and June 30, 2016 , respectively. The changes in the outstanding ABL facilities is due to changes in borrowings related to working capital funding requirements. Partially offsetting the increase in cash provided by financing activities are changes in term debt; inclusive of the Term B Loan, Euro Tranche Term Loan, and Senior Unsecured Note; related to repayments. The January 19, 2017 agreement to amend the Senior Term B loan resulted in a net cash outflow of $4.4 million of financing fees. Refer to “ Note 10: Debt ” in Item 1 of this Quarterly Report on Form 10-Q for additional information.
Cash provided by financing activities also increased by $27.4 million due to a net increase in share-based compensation of $28.1 million and $0.7 million for the six months ended June 30, 2017 and June 30, 2016 , respectively. The change in the share-based compensation is due to cash receipts related to the exercise of stock options, for which there was cash used by financing activities of $7.5 million for taxes paid related to net share settlements of stock-based compensation awards.
The change in short-term financing, net contributed $6.5 million to the decrease in cash provided by financing activities. Short-term financing, net increased by $6.5 million and $5.8 million for the six months ended June 30, 2017 and June 30, 2016 , respectively.
The remaining $0.5 million increase in cash used by financing activities did not contain any significant activity.
Contractual Obligations and Commitments
There were no material changes in our contractual obligations and commitments since the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
Critical Accounting Estimates
There were no material changes in our critical accounting estimates since the filing of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .


34

Table of Contents

Recently Issued and Adopted Accounting Pronouncements
See “ Note 2: Significant accounting policies ” in the notes to the condensed consolidated financial statements.
Accounting Pronouncements Issued But Not Yet Adopted
See “ Note 2: Significant accounting policies ” in the notes to the condensed consolidated financial statements.
Forward looking statements and information
This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some of the forward-looking statements can be identified by the use of forward-looking terms such as “believes,” “expects,” “may,” “will,” “should,” “could,” “seeks,” “intends,” “plans,” “estimates,” “anticipates” or other comparable terms. These forward-looking statements include all matters that are not historical facts. They appear in a number of places throughout this Quarterly Report on Form 10-Q and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our results of operations, financial condition, macro-economic conditions, liquidity, prospects, business trends, currency trends, competition, markets, growth strategies and the industries in which we operate and including, without limitation, statements relating to our estimated or anticipated financial performance or results. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond our control. We caution you that forward-looking statements are not guarantees of future performance and that our actual results of operations, financial condition and liquidity, and the development of the industries in which we operate may differ materially from those made in or suggested by the forward-looking statements contained in this Quarterly Report on Form 10-Q. In addition, even if our results of operations, financial condition and liquidity, and the development of the industries in which we operate are consistent with the forward-looking statements contained in this Quarterly Report on Form 10-Q, those results or developments may not be indicative of results, conditions or developments in subsequent periods. A number of important factors could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including those reflected in forward-looking statements relating to our operations and business and the risks and uncertainties discussed in “Risk Factors.” Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include:
general economic conditions, particularly fluctuations in industrial production and the demands of our customers;
disruptions in the supply of chemicals we distribute or our customers’ or producers' operations;
termination or change of contracts or relationships with customers or producers on short notice;
the price and availability of chemicals, or a decline in the demand for chemicals;
our ability to pass through cost increases to our customers;
our ability to meet customer demand for a product;
trends in oil and gas prices;
our ability to execute strategic investments, including pursuing acquisitions and/or dispositions, and successfully integrating and operating acquired companies;
challenges associated with international operations, including securing producers and personnel, import/export requirements, compliance with foreign laws and international business laws and changes in economic or political conditions;
our ability to effectively implement our strategies or achieve our business goals;
exposure to interest rate and currency fluctuations;
competitive pressures in the chemical distribution industry;
consolidation of our competitors;
our ability to implement and efficiently operate the systems needed to manage our operations;
the risks associated with security threats, including cybersecurity threats;
increases in transportation costs and changes in our relationship with third party carriers;
the risks associated with hazardous materials and related activities;
accidents, safety failures, environmental damage, product quality issues, major or systemic delivery failures involving our distribution network or the products we carry or adverse health effects or other harm related to the materials we blend, manage, handle, store, sell or transport;
evolving laws and regulations relating to hydraulic fracturing and risks associated with chemicals used in hydraulic fracturing;
losses due to potential product liability claims and recalls and asbestos claims;
compliance with extensive environmental, health and safety laws, including laws relating to our environmental services businesses and the investigation and remediation of contamination, that could require material expenditures or changes in our operations;
general regulatory and tax requirements;
operational risks for which we may not be adequately insured;

35

Table of Contents

ongoing litigation and other legal and regulatory actions and risks, including asbestos claims;
potential impairment of goodwill;
inability to generate sufficient working capital;
loss of key personnel;
labor disruptions and other costs associated with the unionized portion of our workforce;
negative developments affecting our pension plans and multi-employer pensions;
the impact of labeling regulations; and
our substantial indebtedness and the restrictions imposed by our debt instruments and indenture.
You should read this Quarterly Report on Form 10-Q, including the uncertainties and factors discussed under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2016 completely and with the understanding that actual future results may be materially different from expectations. All forward-looking statements made in this Quarterly Report on Form 10-Q are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this Quarterly Report on Form 10-Q and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking or cautionary statements to reflect changes in assumptions, the occurrence of events, unanticipated or otherwise and changes in future operating results over time or otherwise.
Comparisons of results between current and prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data.
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
There were no material changes from the “Quantitative and Qualitative Disclosure about Market Risk” disclosed in Part II, Item 7A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
 
Item 4.
Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation as of June 30, 2017 of the effectiveness of the design and operation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were effective as of June 30, 2017 .
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during the quarter ended June 30, 2017 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II.
OTHER INFORMATION
Item 1.        Legal Proceedings
Information pertaining to legal proceedings can be found in Note 14 to the interim condensed consolidated financial statements included in Part I, Financial Statements of this report.
Item 1A.     Risk Factors
There have been no material changes from the “Risk Factors” disclosed in Part I, Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 .
Item 2.         Unregistered Sales of Equity Securities and Use of Proceeds
None.
Item 3.         Defaults Upon Senior Securities
None.


36

Table of Contents

Item 4.         Mine Safety Disclosures
None.
Item 5.         Other Information
On May 4, 2017, the Company executed a waiver of certain confidentiality and other provisions in existing agreements with current and former employees, which waiver is intended to confirm such agreements are to be interpreted consistent with applicable law, including specifically Section 21F of the Securities Exchange Act of 1934. 
Item 6.         Exhibits
Exhibit Number
Exhibit Description
 
 
10.1†*
 
Form of Employee Performance Restricted Stock Unit Agreement, 2017 Omnibus Equity Incentive Plan.
 
 
 
31.1*
 
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
31.2*
 
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
 
 
32.1**
 
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
32.2**
 
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
 
101.1*
 
Interactive Data File
_______________________
Identifies each management compensation plan or arrangement.
*
Filed herewith
**
Furnished herewith

37

Table of Contents

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
Univar Inc.
(Registrant)
 
 
By:
 
/s/ Stephen D. Newlin
 
 
Stephen D. Newlin
Chief Executive Officer
Date: August 4, 2017
 
By:
 
/s/ Carl J. Lukach
 
 
Carl J. Lukach
Executive Vice President, Chief Financial Officer
Date: August 4, 2017


38



Form of Employee Performance Restricted Stock Unit Agreement
This Employee Performance Restricted Stock Unit Agreement (the “ Agreement ”), by and between Univar Inc., a Delaware corporation (the “ Company ”), and the Employee whose name is set forth on Exhibit A hereto, is being entered into pursuant to the Univar Inc. 2017 Omnibus Equity Incentive Plan (as amended from time to time, the “ Plan ”). This Agreement shall be dated as of the date it is accepted and agreed to by the Employee in accordance with Section 6(s). Capitalized terms that are used but not defined herein shall have the respective meanings given to them in the Plan.
Section 1.      Grant of Performance Restricted Stock Units . The Company hereby evidences and confirms its grant to the Employee, effective as of the date set forth on Exhibit A hereto (the “ Grant Date ”), of the number of Performance Restricted Stock Units (“ PRSUs ”) as shall be determined pursuant to Exhibit A and Section 2 hereof, subject to adjustment pursuant to the Plan. Each PRSU that becomes earned and vested in accordance with the terms of this Agreement (including Exhibit A ) will entitle the Employee to receive from the Company one (1) share of Company Common Stock as provided under Section 3. This Agreement is entered into pursuant to, and the PRSUs granted hereunder are subject to, the terms and conditions of the Plan, which are incorporated by reference herein. If there is any inconsistency between any express provision of this Agreement and any express term of the Plan, the express term of the Plan shall govern.
Section 2.      Vesting of Performance Restricted Stock Units .
(a)      Vesting . Except as otherwise provided in this Section 2, the PRSUs shall become earned and vested, if at all, in accordance with the terms and conditions of this Agreement (including, but not limited to, the provisions relating to the earning, vesting and forfeiture of PRSUs as set forth on Exhibit A ) and the Plan, subject to the continued employment of the Employee by the Company or any Subsidiary thereof through the Vesting Date set forth on Exhibit A . Earned PRSUs (as defined on Exhibit A ) that become vested shall be settled as provided in Section 3 of this Agreement.
(b)      Effect of Termination of Employment .
(i)      If the Employee’s employment is terminated by reason of the Employee’s death, Disability or retirement at normal retirement age (such termination, a “ Special Termination ”) prior to the Vesting Date, ( x ) any PRSUs that are Earned PRSUs for the Performance Period(s) prior to the Performance Period during which the Employee’s employment is terminated shall vest as of the date of such Special Termination, and ( y ) any PRSUs that are not Earned PRSUs for the Performance Period(s) prior to the Performance Period during which the Employee’s employment is terminated (which for avoidance of doubt shall include any PRSUs subject to be earned for the Performance Period(s) in which the Special Termination occurs or subject to be earned in respect of Performance Period(s) not yet commenced as of the date of the Special Termination) shall automatically be forfeited and canceled as of the effective date of such Special Termination.





Vested PRSUs shall be settled as provided in Section 3 of this Agreement. For purposes of this Agreement, “ normal retirement age ” has the meaning provided in the Company’s customary policies, or, if not provided therein, age 65 or older.
(ii)      Any Other Reason . Upon termination of the Employee’s employment prior to the Vesting Date for any reason other than a Special Termination (whether initiated by the Company or by the Employee), all PRSUs (including any Earned PRSUs that have not vested) shall be forfeited and canceled for no consideration effective as of the date of such termination.
(c)      Effect of a Change in Control . A Change in Control that is consummated prior to the Vesting Date shall not accelerate the vesting or settlement of unvested PRSUs; provided , however , that if the Administrator reasonably determines in good faith, prior to the occurrence of the Change in Control, that no Alternative Awards will be provided in respect of PRSUs, ( i ) the Earned PRSUs shall vest and ( ii ) any PRSUs that are not Earned PRSUs shall vest at the Target Amount, in each case effective as of the date of the Change in Control.
(d)      Discretionary Acceleration . Notwithstanding anything contained in this Agreement to the contrary, but subject to any limits prescribed in the Plan, the Administrator, in its sole discretion, may accelerate the vesting with respect to any PRSUs under this Agreement, at such times and upon such terms and conditions as the Administrator shall determine; provided, that the acceleration of vesting of PRSUs that are subject to Section 409A of the Code shall not accelerate the Settlement Date thereof unless permitted by Section 409A of the Code.
(e)      No Other Accelerated Vesting . The vesting and settlement provisions set forth in this Section 2, or in Section 3, or expressly set forth in the Plan, shall be the exclusive vesting and settlement provisions applicable to the PRSUs and shall supersede any other provisions relating to vesting and settlement, unless such other such provision expressly refers to the Plan by name and this Agreement by name and date.
Section 3.      Settlement of PRSUs .
(a)      Timing of Settlement . Subject to Section 6(a), any Earned PRSUs that become vested on the Vesting Date shall be settled into an equal number of shares of Company Common Stock on a date selected by the Company that is on or within 30 days following the date of the Administrator’s certification of achievement of the Performance Goals for the applicable Performance Period(s) that include the Vesting Date, but not later than March 15 th of the calendar year immediately following the Vesting Date (each such date, a “ Settlement Date ”); provided , that, in the case of accelerated vesting of PRSUs pursuant to Section 2(b)(i) or 2(c) (but, for PRSUs that are subject to Section 409A of the Code, only if permitted by Section 409A of the Code), the Settlement Date shall occur on a date selected by the Company that is within 30 days following the vesting of such PRSUs.
(b)      Mechanics of Settlement . On the Settlement Date, the Company shall electronically issue to the Employee one whole share of Company Common Stock for each PRSU that became earned and





vested as of the Settlement Date (except as provided in Section 6(a)), and, upon such issuance, the Employee’s rights in respect of such PRSU shall be extinguished. On or before any Settlement Date, at the Company’s request, the Company and the Employee shall enter into a Subscription Agreement that establishes the rights and obligations of the Company and the Employee relating to the shares of Company Common Stock issued in respect of the PRSUs, in the form then customarily used by the Company under the Plan for such purpose. In the event that there are any fractional PRSUs that became vested on such date, such fractional PRSUs shall be settled through a cash payment equal to such fractional PRSU multiplied by the Fair Market Value of one (1) share of Company Common Stock on the Settlement Date. No fractional shares of Company Common Stock shall be issued in respect of the PRSUs.
Section 4.      Securities Law Compliance . Notwithstanding any other provision of this Agreement, the Employee may not sell the shares of Company Common Stock acquired upon settlement of the PRSUs unless such shares are registered under the Securities Act of 1933, as amended (the “ Securities Act ”), or, if such shares are not then so registered, such sale would be exempt from the registration requirements of the Securities Act. The sale of such shares must also comply with other applicable laws and regulations governing the Company Common Stock, and the Employee may not sell the shares of Company Common Stock if the Company determines that such sale would not be in material compliance with such laws and regulations.
Section 5.      Restriction on Transfer; Non-Transferability of PRSUs . The PRSUs are not assignable or transferable, in whole or in part, and they may not, directly or indirectly, be offered, transferred, sold, pledged, assigned, alienated, hypothecated or otherwise disposed of or encumbered (including, but not limited to, by gift, operation of law or otherwise) other than by will or by the laws of descent and distribution to the estate of the Employee upon the Employee’s death. Any purported transfer in violation of this Section 5 shall be void ab initio .
Section 6.      Miscellaneous .
(a)      Tax Matters
(i)      Tax Withholding . In the event that the Company settles any PRSUs using Company Common Stock, the Company or one of the Subsidiaries shall require the Employee to remit to the Company an amount in cash sufficient to satisfy any applicable U.S. federal, state and local and non-U.S. tax withholding obligations that may arise in connection with the vesting of the PRSUs and the related issuance of shares of Company Common Stock. Notwithstanding the preceding sentence, if the Employee elects not to remit cash in respect of such obligations, ( x ) the Company shall retain a number of shares of Company Common Stock issued in respect of the PRSUs then vesting that have an aggregate Fair Market Value as of the Settlement Date equal to the amount of such taxes required to be withheld not in excess of such amount as may be necessary to avoid liability award accounting and any remaining amount shall be remitted in cash or withheld and ( y ) the number of shares of Company Common Stock to be issued in respect of the PRSUs shall thereupon be reduced by the number of shares of Company Common Stock so





retained (and the Employee shall thereupon be deemed to have satisfied his or her obligations under this Section 6(a)). The method of withholding set forth in the immediately preceding sentence shall not be available if withholding in this manner would violate any financing instrument of the Company or any of the Subsidiaries.
(ii)      Compliance with Section 409A of the Code . If the Employee is not eligible for Retirement during the vesting period applicable to the PRSUs, the PRSUs are intended to be exempt from Section 409A of the Code. If the Employee is eligible for Retirement during the vesting period applicable to the PRSUs such that some or all of the PRSUs are subject to Section 409A of the Code, this Agreement and the PRSUs shall administered and interpreted in compliance with Section 409A of the Code to the extent applicable. Notwithstanding the foregoing, if the Company determines that the PRSUs may not either be exempt from or compliant with Section 409A of the Code, the Company may adopt such amendments or other policies and procedures (including amendments, policies and procedures with retroactive effect), or take any other actions, that the Company determines are necessary or appropriate, as applicable, to ( x ) exempt the PRSUs from Section 409A of the Code, or ( y ) comply with the requirements of Section 409A of the Code; provided, however , that there is no obligation on the part of the Company to adopt any such amendment, policy or procedure or take any such other action. If the Employee is a “specified employee” as defined in Section 409A of the Code as of the Employee’s separation from service, to the extent any PRSUs are subject to Section 409A of the Code, then to the extent required by Section 409A of the Code, no payments due under this Agreement may be made until the earlier of: ( A ) the first day of the seventh month following the Employee’s separation from service, or ( B ) the Employee’s date of death. If this Agreement fails to comply with the requirements of Section 409A of the Code, neither the Company nor any of its Affiliates shall have any liability for any tax, penalty or interest imposed on the Employee by Section 409A of the Code, and the Employee shall have no recourse against the Company or any of its Affiliates for payment of any such tax, penalty or interest imposed by Section 409A of the Code.
(b)      Dividend Equivalents . In the event that the Company pays any ordinary dividend in cash on a share of Company Common Stock following the Grant Date and prior to the Date with respect to any PRSUs, there shall be credited to the account of the Employee in respect of each outstanding PRSU an amount equal to the amount of such dividend. The amount so credited shall be deferred (without interest, unless the Administrator determines otherwise) until the applicable Settlement Date of the PRSUs and then paid in cash proportionate to the amount of the PRSUs, if any, that have been earned or vested, but to the extent any PRSUs are canceled a proportionate amount of such accumulated amounts shall be forfeited.
(c)      Authorization to Share Personal Data . The Employee authorizes the Company or any Affiliate of the Company that has or lawfully obtains personal data relating to the Employee to divulge or transfer such personal data to the Company or to a third party, in each case in any jurisdiction, if and to the extent reasonably appropriate in connection with this Agreement or the administration of the Plan.





(d)      No Rights as Stockholder; No Voting Rights . Except as provided in Section 6(b), the Employee shall have no rights as a stockholder of the Company with respect to any shares of Company Common Stock covered by the PRSUs prior to the issuance of such shares of Company Common Stock.
(e)      No Right to Awards . The Employee acknowledges and agrees that the grant of any PRSUs ( i ) is being made on an exceptional basis and is not intended to be renewed or repeated, ( ii ) is entirely voluntary on the part of the Company and the Subsidiaries and ( iii ) should not be construed as creating any obligation on the part of the Company or any of the Subsidiaries to offer any PRSUs or other Awards in the future.
(f)      No Right to Continued Employment . Nothing in this Agreement shall be deemed to confer on the Employee any right to continue in the employ of the Company or any Subsidiary, or to interfere with or limit in any way the right of the Company or any Subsidiary to terminate such employment at any time.
(g)      Nature of Award . This award of PRSUs and any delivery or payment in respect thereof constitutes a special incentive payment to the Employee and shall not be taken into account in computing the amount of salary or compensation of the Employee for the purpose of determining any retirement, death or other benefits under ( x ) any retirement, bonus, life insurance or other employee benefit plan of the Company, or ( y ) any agreement between the Company and the Employee, except as such plan or agreement shall otherwise expressly provide.
(h)      Interpretation . The Administrator shall have full power and discretion to construe and interpret the Plan (and any rules and regulations issued thereunder) and this Award. Any determination or interpretation by the Administrator under or pursuant to the Plan, this Agreement (including Exhibit A) or this Award shall be final and binding and conclusive on all persons affected hereby.
(i)      Forfeiture of Awards . The PRSUs granted hereunder (and gains earned or accrued in connection therewith) shall be subject to such generally applicable policies as to forfeiture and recoupment (including, without limitation, upon the occurrence of material financial or accounting errors, financial or other misconduct or Competitive Activity) as may be adopted by the Administrator or the Board from time to time and communicated to the Employee or as required by Applicable Law, and are otherwise subject to forfeiture or disgorgement of profits as provided by the Plan.
(j)      Consent to Electronic Delivery . By entering into this Agreement and accepting the PRSUs evidenced hereby, the Employee hereby consents to the delivery of information (including, without limitation, information required to be delivered to the Employee pursuant to applicable securities laws) regarding the Company and the Subsidiaries, the Plan, this Agreement and the PRSUs via Company website or other electronic delivery.
(k)      Binding Effect; Benefits . This Agreement shall be binding upon and inure to the benefit of the parties to this Agreement and their respective successors and assigns. Nothing in this Agreement, express or implied, is intended or shall be construed to give any person other than the parties to this





Agreement or their respective successors or assigns any legal or equitable right, remedy or claim under or in respect of any agreement or any provision contained herein.
(l)      Waiver; Amendment .
(i)      Waiver . Any party hereto or beneficiary hereof may by written notice to the other parties ( A ) extend the time for the performance of any of the obligations or other actions of the other parties under this Agreement, ( B ) waive compliance with any of the conditions or covenants of the other parties contained in this Agreement and ( C ) waive or modify performance of any of the obligations of the other parties under this Agreement. Except as provided in the preceding sentence, no action taken pursuant to this Agreement, including, without limitation, any investigation by or on behalf of any party or beneficiary, shall be deemed to constitute a waiver by the party or beneficiary taking such action of compliance with any representations, warranties, covenants or agreements contained herein. The waiver by any party hereto or beneficiary hereof of a breach of any provision of this Agreement shall not operate or be construed as a waiver of any preceding or succeeding breach and no failure by a party or beneficiary to exercise any right or privilege hereunder shall be deemed a waiver of such party’s or beneficiary’s rights or privileges hereunder or shall be deemed a waiver of such party’s or beneficiary’s rights to exercise the same at any subsequent time or times hereunder.
(ii)      Amendment . This Agreement may not be amended, modified or supplemented orally, but only by a written instrument executed by the Employee and the Company.
(m)      Assignability . Neither this Agreement nor any right, remedy, obligation or liability arising hereunder or by reason hereof shall be assignable by the Company or the Employee without the prior written consent of the other party.
(n)      Applicable Law . This Agreement shall be governed in all respects, including, but not limited to, as to validity, interpretation and effect, by the internal laws of the State of Delaware, without reference to principles of conflict of law that would require application of the law of another jurisdiction.
(o)      Waiver of Jury Trial . Each party hereby waives, to the fullest extent permitted by applicable law, any right he, she or it may have to a trial by jury in respect of any suit, action or proceeding arising out of this Agreement or any transaction contemplated hereby. Each party ( i ) certifies that no representative, agent or attorney of any other party has represented, expressly or otherwise, that such other party would not, in the event of litigation, seek to enforce the foregoing waiver and ( ii ) acknowledges that he, she or it and the other party hereto have been induced to enter into the Agreement by, among other things, the mutual waivers and certifications in this Section 6(o).
(p)      Limitations of Actions . No lawsuit relating to this Agreement may be filed before a written claim is filed with the Administrator and is denied or deemed denied as provided in the Plan and any lawsuit must be filed within one year of such denial or deemed denial or be forever barred.





(q)      Section and Other Headings, etc . The section and other headings contained in this Agreement are for reference purposes only and shall not affect the meaning or interpretation of this Agreement.
(r)      Restrictive Covenants . In consideration of the receipt of the Restricted Stock Units granted pursuant to this Agreement, if requested by the Administrator as evidenced by the attachment of Exhibit B hereto, the Employee agrees to be bound by the covenants set forth in Exhibit B to this Agreement, which are incorporated by reference and made part of this Agreement.
(s)      Acceptance of PRSUs and Agreement . The Employee has indicated his or her consent and acknowledgement of the terms of this Agreement pursuant to the instructions provided to the Employee by or on behalf of the Company. The Employee acknowledges receipt of the Plan, represents to the Company that he or she has read and understood this Agreement and the Plan, and, as an express condition to the grant of the PRSUs under this Agreement, agrees to be bound by the terms of both this Agreement and the Plan. The Employee and the Company each agrees and acknowledges that the use of electronic media (including, without limitation, a clickthrough button or checkbox on a website of the Company or a third-party administrator) to indicate the Employee’s confirmation, consent, signature, agreement and delivery of this Agreement and the PRSUs is legally valid and has the same legal force and effect as if the Employee and the Company signed and executed this Agreement in paper form. The same use of electronic media may be used for any amendment or waiver of this Agreement.








Exhibit A to
Employee Performance Restricted Stock Unit Agreement
Employee:
__________________________
Grant Date:
________________, 201__
Target Amount of Performance Restricted Stock Units granted hereby (the “ Target Amount ”):
__________________________
Vesting Date:
________________, 201__
1.     Performance Restricted Stock Units . The total number of PRSUs subject to this Award will be determined in a range of 0% to 200% of the Target Amount, subject to the terms and conditions set forth below. Twenty-five percent (25%) of the Target Award (each such 25% portion, a “ Tranche ”) shall be eligible to be earned in respect of each Performance Period based on achievement of the applicable Performance Goal for such period. The earned PRSUs shall vest on the Vesting Date specified above, subject to the continued employment of the Employee by the Company or any Subsidiary thereof through the Vesting Date, except as otherwise set forth in the Agreement.
2.      Performance Period . “ Performance Period ” means each of the following four periods during which a Tranche is eligible to be earned:
·
Year 1 Performance : the one (1)-year period commencing January 1, 201_ and ending December 31, 201_ (“ Tranche 1 ”);
·
Year 2 Performance : the one (1)-year period commencing January 1, 201_ and ending December 31, 201_ (“ Tranche 2 ”);
·
Year 3 Performance : the one (1)-year period commencing January 1, 201_ and ending December 31, 201_ (“ Tranche 3 ”); and
·
Cumulative Performance : the three (3)-year period commencing January 1, 201_ and ending December 31, 201_ (“ Tranche 4 ”).
3.      Performance Goals; Administrator Certification .
(a)      Performance Goals . The total number of PRSUs which shall be earned with respect to each Tranche shall be determined based on the Company’s performance against the applicable Performance Goal during the applicable Performance Period, as set forth in the table below. The Administrator shall establish Performance Goals for the applicable Performance Period prior to the ninety-first (91 st ) day of the Performance Cycle (or by such other date as may be required under Section





162(m) of the Code) but not later than the date on which 25% of the Performance Cycle has elapsed. Payout of each Tranche as a percentage of Target shall be (i) 0% for performance below “threshold”, (ii) 50% for performance at “threshold”, (iii) 100% for performance at “target” and (iv) 200% for performance at or above “maximum”, with the applicable “threshold,” “target” and “maximum” set forth in the table below. For achievement between threshold and target performance, or between target and maximum performance, the number of PRSUs earned in each case shall be interpolated on a straight-line basis.
Tranche
Performance Period
Portion of Target Award
Performance Goal
Performance Goal
Threshold
Target
Maximum
Tranche 1
January 1, 201_ to December 31, 201_
25%
Reported Adjusted EBITDA for Performance Period
__
__
__
Tranche 2
January 1, 201_ to December 31, 201_
25%
Reported Adjusted EBITDA for Performance Period
__
__
__
Tranche 3
January 1, 201_ to December 31, 201_
25%
Reported Adjusted EBITDA for Performance Period
__
__
__
Tranche 4
January 1, 201_ to December 31, 201_
25%
Cumulative Reported Adjusted EBITDA for Performance Period
__
__
__
The PRSUs in each Tranche shall become “ Earned PRSUs ” as of the last day of of the Performance Period to the extent earned in accordance with the applicable Performance Goal, subject to the Administrator certifying the achievement of the applicable Performance Goal pursuant to Section 3(b) of Exhibit A . Any PRSUs in respect of a Tranche that do not become Earned PRSUs shall be forfeited and canceled as of the date of the Administrator’s certification pursuant to Section 3(b) of this Exhibit A .
For the avoidance of doubt, ( x ) if the performance results for the applicable Performance Period (as certified by the Administrator pursuant to Section 3(b) of this Exhibit A ) do not meet or exceed the threshold level of achievement of the applicable Performance Goal, the Tranche of PRSUs eligible to be earned in respect of such Performance Period shall immediately be forfeited and canceled, and ( y ) in no event shall the number of PRSUs earned in respect of each Tranche exceed the maximum amount for such Tranche.
For clarity, Reported Adjusted EBITDA shall not be further adjusted for foreign exchange or acquisitions/divestitures.
(b)      Certification of Achievement Relative to Performance Goal . As soon as practicable after the end of a Performance Period but in any event within forty-five (45) days after the end of such Performance Period, the Administrator shall certify in writing the extent to which the Performance Goal has been achieved with respect to the applicable Performance Period.






Exhibit B to
Employee Restricted Stock Unit Agreement
Restrictive Covenants
Section 1 Confidential Information .
1.1      The Employee recognizes that the success of the Company and its current or future Affiliates depends upon the protection of information or materials that are designated as confidential and/or proprietary at the time of disclosure or should, based on their nature or the circumstances surrounding such disclosure, reasonably be deemed confidential including, without limitation, information to which the Employee has access while employed by the Company whether recorded in any medium or merely memorized (all such information being “ Confidential Information ”). “Confidential Information” includes without limitation, and whether or not such information is specifically designated as confidential or proprietary: all business plans and marketing strategies; information concerning existing and prospective markets, suppliers and customers; financial information; information concerning the development of new products and services; and technical and non-technical data related to software programs, design, specifications, compilations, Inventions (as defined in Section 3.1), improvements, patent applications, studies, research, methods, devices, prototypes, processes, procedures and techniques. Confidential Information expressly includes information provided to the Company or its Affiliates by third parties under circumstances that require them to maintain the confidentiality of such information. Notwithstanding the foregoing, the Employee shall have no confidentiality obligation with respect to disclosure of any Confidential Information that ( a ) was, or at any time becomes, available in the public domain other than through a violation of this Agreement or ( b ) the Employee can demonstrate by written evidence was furnished to the Employee by a third party in lawful possession thereof and who was not under an obligation of confidentiality to the Company or any of its Affiliates.
1.2      The Employee agrees that during the Employee’s employment and after termination of employment irrespective of cause, the Employee will use Confidential Information only for the benefit of the Company and its Affiliates. Notwithstanding the foregoing, the Employee may disclose Confidential Information as ( a ) authorized by applicable law (including, but not limited to, any disclosure of information that satisfies the procedures in SEC Regulation § 240.21F-17) or ( b ) as required pursuant to an order or requirement of a court, administrative agency or other government body.
1.3      The Employee hereby assigns to the Company any rights the Employee may have or acquire in such Confidential Information and acknowledges that all Confidential Information shall be the sole property of the Company and/or its Affiliates or their assigns.
1.4      There are no rights granted or any understandings, agreements or representations between the parties hereto, express or implied, regarding Confidential Information that are not specified herein.





1.5      The Employee’s obligations under this Section 1 are in addition to any obligations that the Employee has under state or federal law.
1.6      The Employee agrees that in the course of the Employee’s employment with the Company, the Employee will not violate in any way the rights that any entity, including former employers, has with regard to trade secrets or proprietary or confidential information.
1.7      The Employee’s obligations under this Section 1 are indefinite in term and shall survive the termination of this Agreement.
Section 2 Return of Company Property .
2.1      The Employee acknowledges that all tangible items containing any Confidential Information, including without limitation memoranda, photographs, records, reports, manuals, drawings, blueprints, prototypes, notes, documents, drawings, specifications, software, media and other materials, including any copies thereof (including electronically recorded copies), are the exclusive property of the Company or its applicable Affiliate, and the Employee shall deliver to the Company all such material in the Employee’s possession or control upon the Company’s request and in any event upon the termination of the Employee’s employment with the Company. The Employee shall also return any keys, equipment, identification or credit cards, or other property belonging to the Company or its Affiliates upon termination of the Employee’s employment or request.
Section 3 Inventions .
3.1      The Employee understands and agrees that all Inventions are the exclusive property of the Company. As used in this Agreement, “ Inventions ” shall include without limitation ideas, discoveries, developments, concepts, inventions, original works of authorship, trademarks, mask works, trade secrets, ideas, data, information, know-how, documentation, formulae, results, prototypes, designs, methods, processes, products, formulas and techniques, improvements to any of the foregoing, and all other matters ordinarily intended by the words “intellectual property,” whether or not patentable, copyrightable, or otherwise able to be registered, which are developed, created conceived of or reduced to practice by the Employee, alone or with others, during the Employee’s employment with the Company or Affiliates, whether or not during working hours or within three (3) months thereafter and related to the Company’s then existing or proposed business. In recognition of the Company’s ownership of all Inventions, the Employee shall make prompt and full disclosure to the Company of, will hold in trust for the sole benefit of the Company, and (subject to Section 3.2 below) herby assigns, and agrees to assign in the future, exclusively to the Company all of the Employee’s right, title, and interest in and to any and all such Inventions.
3.2      NOTICE REQUIRED BY REVISED CODE OF WASHINGTON 49.44.140 : The Employee understands that the Employee’s obligation to assign inventions shall not apply to any inventions for which no equipment, supplies, facilities, or trade secret information of the Company was used and that was developed entirely on the Employee’s own time, unless (a) the invention relates (i)





directly to the business of the Company, or (ii) to the Company’s actual or demonstrably anticipated research or development, or (b) the invention results from any work performed by the Employee for the Company.
3.3      To the extent any works of authorship created by the Employee made within the scope of employment may be considered “works made for hire” under United States copyright laws, they are hereby agreed to be works made for hire. To the extent any such works do not qualify as a “work made for hire” under applicable law, and to the extent they include material subject to copyright, the Employee hereby irrevocably and exclusively assigns and conveys all rights, title and interests in such works to the Company subject to no liens, claims or reserved rights. The Employee hereby waives any and all “moral rights” that may be applicable to any of the foregoing, for any and all uses, alterations, and exploitation hereof by the Company, or its Affiliates, or their successors, assignees or licensees. To the extent that any such “moral rights” may not be waived in accordance with law, the Employee agrees not to bring any claims, actions or litigation against the Company or its Affiliates, or their successors, assignees or licensees, based on or to enforce such rights. Without limiting the preceding, the Employee agrees that the Company may in its discretion edit, modify, recast, use, and promote any such works of authorship, and derivatives thereof, with or without the use of the Employee’s name or image, without compensation to the Employee other than that expressly set forth herein.
3.4      The Employee hereby waives and quitclaims to the Company any and all claims of any nature whatsoever that the Employee now or hereafter may have for infringement of any patent or patents from any patent applications for any Inventions. The Employee agrees to cooperate fully with the Company and take all other such acts requested by the Company (including signing applications for patents, assignments, and other papers, and such things as the Company may require) to enable the Company to establish and protect its ownership in any Inventions and to carry out the intent and purpose of this Agreement, during the Employee’s employment or thereafter. If the Employee fails to execute such documents by reason of death, mental or physical incapacity or any other reason, the Employee hereby irrevocably appoints the Company and its officers and agents as the Employee’s agent and attorney-in-fact to execute such documents on the Employee’s behalf.
3.5      The Employee agrees that there are no Inventions made by the Employee prior to the Employee’s employment with the Company and belonging to the Employee that the Employee wishes to have excluded from this Section 3 (the “ Excluded Inventions ”). If during the Employee’s employment with the Company, the Employee uses in the specifications or development of, or otherwise incorporates into a product, process, service, technology, or machine of the Company or its Affiliates, or otherwise uses any invention, proprietary know-how, or other intellectual property in existence before the commencement date of Employee’s employment with the Company or any Affiliate owned by the Employee or in which the Employee has any interest (“ Existing Know-How ”), the Company or its Affiliates, as the case may be, is hereby granted and shall have a non-exclusive, royalty-free, fully paid up, perpetual, irrevocable, worldwide right and license under the Existing Know-How (including any patent or other intellectual property rights therein) to make, have made, use, sell, reproduce, distribute, make derivative works from, publicly perform and display, and import, and to sublicense any and all of





the foregoing rights to that Existing Know-How (including the right to grant further sublicenses) without restriction as to the extent of the Employee’s ownership or interest, for so long as such Existing Know-How is in existence and is licensable by the Employee.
Section 4 Nonsolicitation and Noncompetition .
4.1      During the Employee’s employment with the Company, and for a period expiring eighteen (18) months after the termination of the Employee’s employment (the “ Restrictive Period ”), regardless of the reason, if any, for such termination, the Employee shall not, in the United States, Western Europe or Canada, directly or indirectly:
(a)      solicit or entice away or in any other manner persuade or attempt to persuade any officer, employee, consultant or agent of the Company or any of its Affiliates to alter or discontinue his or her relationship with the Company or its Affiliates;
(b)      solicit from any person or entity that was a customer of the Company or any of its Affiliates during the Employee’s employment with the Company, any business of a type or nature similar to the business of the Company or any of its Affiliates with such customer;
(c)      solicit, divert, or in any other manner persuade or attempt to persuade any supplier of the Company or any of its Affiliates to discontinue its relationship with the Company or its Affiliates;
(d)      solicit, divert, take away or attempt to solicit, divert or take away any customers of the Company or its Affiliates; or
(e)      engage in or participate in the chemical distribution or logistics business.
4.2      Nothing in Section 4.1 limits the Employee’s ability to hire an employee of the Company or any of its Affiliates in circumstances under which such employee first contacts the Employee regarding employment and the Employee does not violate any of subsections 4.1(a), 4.1(b), 4.1(c), 4.1(d) or 4.1(e) herein.
4.3      The Company and the Employee agree that the provisions of this Section 4 do not impose an undue hardship on the Employee and are not injurious to the public; that this provision is necessary to protect the business of the Company and its Affiliates; that the nature of the Employee’s responsibilities with the Company under this Agreement provide and/or will provide the Employee with access to Confidential Information that is valuable and confidential to the Company and its Affiliates; that the Company would not grant Options to the Employee if the Employee did not agree to the provisions of this Section 4; that this Section 4 is reasonable in terms of length of time and scope; and that adequate consideration supports this Section 4. In the event that a court determines that any provision of this Section 4 is unreasonably broad or extensive, the Employee agrees that such court should narrow such provision to the extent necessary to make it reasonable and enforce the provisions as narrowed.





4.4      Clawback .
(a)      Without limiting the generality of the remedies available to the Company pursuant to Section 4.3, if, during the Restrictive Period, the Employee, except with the prior written consent of the Board, materially breaches the restrictive covenants contained in Section 4, the Employee shall pay to the Company in cash any gain the Employee realized in cash in connection with the exercise of the Options (and/or sale of Common Stock underlying the Options) within the eighteen-month period (or such other period as determined by the Board) ending on the date of the Employee’s breach. This right of recoupment is in addition to any other remedies the Company may have against the Employee for the Employee’s breach of the restrictive covenants contained in this Section 4. The Employee’s obligations under this Exhibit A shall be cumulative (but not duplicative, nor operate to extend the length of any such obligations) of any similar obligations the Employee has under the Plan, the Agreement or any other agreement with the Company or any Affiliate.
Section 5 Definitions . As used in this Exhibit B, capitalized terms that are not defined herein have the respective meaning given in the Plan or the Agreement.







Exhibit 31.1
CERTIFICATION OF CHIEF EXECUTIVE OFFICER
PURSUANT TO RULE 13a-14(a) OF THE EXCHANGE ACT, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Stephen D. Newlin, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Univar Inc.
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 4, 2017
By: /s/  Stephen D. Newlin
 
 
 Stephen D. Newlin
 
 
 Chief Executive Officer
 





Exhibit 31.2
CERTIFICATION OF CHIEF FINANCIAL OFFICER
PURSUANT TO RULE 13a-14(a) OF THE EXCHANGE ACT, AS AMENDED,
AS ADOPTED PURSUANT TO
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002
I, Carl J. Lukach, certify that:

1.
I have reviewed this quarterly report on Form 10-Q of Univar Inc.
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)), and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)), for the registrant and have:
(a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected or is reasonably likely to materially affect the registrant’s internal control over financial reporting; and
5.
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
(a)
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
 
Date: August 4, 2017
By: /s/  Carl J. Lukach
 
 
Carl J. Lukach
 
 
Executive Vice President and Chief Financial Officer
 





Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q (the “Report”) for the quarter ended June 30, 2017 , I, Stephen D. Newlin, Chief Executive Officer of Univar Inc. (the “Company”), certify that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ STEPHEN D. NEWLIN
Stephen D. Newlin
Chief Executive Officer
August 4, 2017

This certification accompanies the Report and shall not, except to the extent required by the Exchange Act, be deemed filed by the Company. A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or it staff upon request.





Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q (the “Report”) for the quarter ended June 30, 2017 , I, Carl J. Lukach, Executive Vice President and Chief Financial Officer of Univar Inc. (the “Company”), certify that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (the “Exchange Act”); and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ CARL J. LUKACH
Carl J. Lukach
Executive Vice President and Chief Financial Officer
August 4, 2017

This certification accompanies the Report and shall not, except to the extent required by the Exchange Act, be deemed filed by the Company. A signed original of this certification has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or it staff upon request.